Heart failure,strict

I9_HEARTFAIL_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I11.0, I13.0, I13.2, I50 Hospital discharge: ICD-9 — 4029B\|428 Hospital discharge: ICD-8 — 42700\|42710\|428\|7824 Cause of death: ICD-10 — I11.0, I13.0, I13.2, I50 Cause of death: ICD-9 — 4029B\|428 Cause of death: ICD-8 — 42700\|42710\|428\|7824 KELA reimbursements: KELA codes — 201 Medicine purchases: ATC — C03CA01\|C03EB01 4 out of 7 registries used, show all original rules.	-
4. Check minimum number of events Min. number of events 3, and need other rules	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: I9_HEARTFAIL_NS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF6

NAME	I9_HEARTFAIL_EXMORE
CONTROL_EXCLUDE	I9_HEARTFAIL_NS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I50\|I110\|I130\|I132
HD_ICD_9	4029B\|428
HD_ICD_8	42700\|42710\|428\|7824
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I50\|I110\|I130\|I132
COD_ICD_9	4029B\|428
COD_ICD_8	42700\|42710\|428\|7824
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	201
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER	YES
KELA_ATC	C03CA01\|C03EB01
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Heart failure,strict based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	488284	258381	222422
Only index persons	306110	164935	141175
Unadjusted period prevalence (%)
Whole population	6.87	7.40	6.21
Only index persons	5.75	6.06	5.39
Median age at first event (years)
Whole population	73.72	75.74	71.47
Only index persons	74.89	77.35	72.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	41591	16286	25305
Unadjusted period prevalence (%)	9.32	5.78	11.59
Median age at first event (years)	71.77	72.44	71.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
26956: Matched controls
190137

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

436.6

321.2

367

3AC01, ,

NOMESCO Finland

10.9

319.2

418

275

A04

ICPC

Weakness/tiredness general

2.1

318.6

3807

13908

C07AB03

ATC

atenolol; systemic

2.7

318.3

1994

5458

I34.1

ICD-10 Finland

Mitral (valve) prolapse

4.0

316.1

1029

1859

Coronary artery bypass surgery

4.7

315.2

841

1291

J81

ICD-10 Finland

Pulmonary oedema

20.3

313.3

305

107

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.4

313.2

913

1511

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

26.0

313.0

281

Z94.1

ICD-10 Finland

Heart transplant status

80.4

310.5

226

196

Kela drug reimbursment

Paricalcitol and cinacalcet

61.4

309.9

233

I20.00

ICD-10 Finland

Unstable angina

3.7

309.7

1110

2154

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.8

309.6

1070

2022

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

13742

69247

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.6

307.7

4500

8001

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

9047

36168

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.8

307.7

11052

29135

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

6.1

307.7

913

1091

C02AC05

ATC

moxonidine; oral

3.8

307.7

1763

3460

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

8874

40263

A10BA02

ATC

metformin; oral

2.4

307.7

9968

37345

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.4

307.7

2353

5206

XF400

NOMESCO Finland

ECG with 12 standard connections

2.9

307.7

6162

17492

A10AB01

ATC

insulin (human); parenteral

4.4

307.7

962

1586

B05DA

ATC

Isotonic solutions

37.8

307.7

307

C08CA02

ATC

felodipine; oral

2.3

307.7

3116

10378

I42.0

ICD-10 Finland

Dilated cardiomyopathy

77.3

307.7

3126

322

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

7.5

307.7

1786

1780

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

307.7

1469

2528

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

10.0

307.7

1129

831

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

9.7

307.7

777

580

C07AB02

ATC

metoprolol; systemic

2.5

307.7

7259

24421

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

6.8

307.7

597

631

C10AA05

ATC

atorvastatin; oral

1.9

307.7

13353

65527

A10AB05

ATC

insulin aspart; parenteral

4.5

307.7

3107

5378

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

5.7

307.7

2091

2774

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.3

307.7

3608

8531

AN1

Coronary angiography

4.8

307.7

6152

11077

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

6.9

307.7

749

779

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

307.7

8542

35445

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

6.6

307.7

920

1005

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.8

307.7

523

427

B01AA03

ATC

warfarin; systemic

7.3

307.7

11796

18426

B03XA02

ATC

darbepoetin alfa; parenteral

9.0

307.7

973

787

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

5311

19064

A12BA01

ATC

potassium chloride; oral

6.5

307.7

1993

2316

A46

ICD-10 Finland

Erysipelas

3.5

307.7

6062

14534

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.9

307.7

7801

23691

A10BK03

ATC

empagliflozin; oral

3.3

307.7

3947

9423

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

55.2

307.7

469

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.3

307.7

9184

16767

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

38.7

307.7

559

104

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.0

307.7

2252

3412

ZX120

NOMESCO Finland

Intravenous

2.7

307.7

3159

8827

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.4

307.7

1315

2181

C09DX04

ATC

valsartan and sacubitril; oral

+∞

307.7

1303

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

11.6

307.7

1658

1071

V03AE02

ATC

sevelamer; oral

62.4

307.7

289

201

Kela drug reimbursment

Chronic cardiac insufficiency

+∞

307.7

6112

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

33.4

307.7

392

J96.0

ICD-10 Finland

Acute respiratory failure

9.2

307.7

666

522

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

4750

13763

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.5

307.7

639

710

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

27.8

307.7

343

127

Kela drug reimbursment

Transplant complication

13.4

307.7

687

370

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

10.5

307.7

727

501

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

31.7

307.7

346

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.1

307.7

10414

31949

B01AC04

ATC

clopidogrel; oral

2.7

307.7

6688

20972

A10BK01

ATC

dapagliflozin; oral

4.6

307.7

3495

5975

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

307.7

1287

2461

J01MA14

ATC

moxifloxacin; systemic

2.4

307.7

2698

8371

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.3

307.7

4815

16412

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

40.1

307.7

409

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

457.8

307.7

2949

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

9.3

307.7

3474

2969

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

4811

17696

M10.9

ICD-10 Finland

Gout, unspecified

4.3

307.7

3256

5937

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.8

307.7

1787

3451

J01MA12

ATC

levofloxacin; systemic

2.2

307.7

6000

21949

L04AA06

ATC

mycophenolic acid; systemic

8.6

307.7

758

638

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

307.7

4446

13376

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

23.1

307.7

521

162

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

11.2

307.7

1167

762

XF640, ,

NOMESCO Finland

4.2

307.7

1127

1935

103

Kela drug reimbursment

Diabetes, insulin-treated

2.8

307.7

10247

34105

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

16.0

307.7

1119

512

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

59.1

307.7

323

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

21.1

307.7

625

214

SPAT1229

SPAT

Assessment of need for aid

2.7

307.7

2563

7071

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

27.6

307.7

340

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.0

307.7

1783

4399

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

307.7

2617

4964

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.5

307.7

2895

6259

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.5

307.7

4843

8738

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.2

307.7

2609

6151

C07AB07

ATC

bisoprolol; oral

6.9

307.7

21459

68444

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

7.7

307.7

3086

3154

I25.2

ICD-10 Finland

Old myocardial infarction

5.9

307.7

3774

5096

E87.5

ICD-10 Finland

Hyperkalaemia

8.8

307.7

894

738

A11CC03

ATC

alfacalcidol; systemic

14.5

307.7

1188

601

C01DA14

ATC

isosorbide mononitrate; oral

4.0

307.7

7466

16795

B05DB

ATC

Hypertonic solutions

41.1

307.7

288

TFP20

NOMESCO Finland

Cardiodefibrillation

6.1

307.7

4504

6081

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

307.7

19576

99599

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

307.7

4747

10864

Z94.0

ICD-10 Finland

Kidney transplant status

21.0

307.7

445

152

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

307.7

2065

4582

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.7

307.7

1142

1456

WX872

NOMESCO Finland

Intensive care

4.6

307.7

2534

4161

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

50.2

307.7

524

205

Kela drug reimbursment

Chronic hypertension

2.6

307.7

10437

36626

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.0

307.7

2173

4038

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.5

307.7

8800

15383

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

307.7

2512

6692

A10AA02, ,

ATC

4.3

307.7

976

1647

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

22.4

307.7

1174

385

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

1174

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

4.8

307.7

1333

2045

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

8716

37676

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

10.3

307.7

489

339

B01AB05

ATC

enoxaparin; parenteral

1.9

307.7

9516

41805

A10AE04

ATC

insulin glargine; parenteral

4.0

307.7

4028

7966

AP1

Catheterization of the left side of the heart

6.0

307.7

741

898

E66.00

ICD-10 Finland

Metabolic syndrome

3.7

307.7

1895

3854

E66.9

ICD-10 Finland

Obesity, unspecified

4.6

307.7

1007

1575

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.7

307.7

1545

2003

E66.8

ICD-10 Finland

Other obesity

4.0

307.7

1364

2484

S97

ICPC

Chronic ulcer skin

5.0

307.7

2854

4407

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

307.7

8210

18737

L04AD02

ATC

tacrolimus; systemic

16.8

307.7

422

180

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.8

307.7

2454

6551

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

5.5

307.7

12889

27021

SPAT1255

SPAT

Intravenous administration of medicine

2.7

307.7

2135

5903

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.5

307.7

2005

3324

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.5

307.7

8708

30939

C03AA03

ATC

hydrochlorothiazide; oral

2.5

307.7

3066

9308

C08CA01

ATC

amlodipine; oral

2.0

307.7

12288

57024

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.4

307.7

1408

1920

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

307.7

4310

14710

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

30.6

307.7

1394

338

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

307.7

4889

19120

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

11830

60548

K84

ICPC

Heart disease other

4.1

307.7

1185

2100

A28

ICPC

Limited function/disability NOS

2.8

307.7

6438

19249

A10AC01

ATC

insulin (human); parenteral

4.7

307.7

2998

4948

M10

ICD-10 Finland

Gout

3.1

307.7

1626

3883

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

28.0

307.7

310

C03CA01

ATC

furosemide; systemic

50.7

307.7

22402

16825

E66.01

ICD-10 Finland

Obesity due to excess calories

3.5

307.7

2253

4838

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.2

307.7

1536

3550

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

110.8

307.7

387

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.9

307.7

9558

30138

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.0

307.7

1677

4048

I50.1

ICD-10 Finland

Left ventricular failure

2242.2

307.7

7045

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

53.6

307.7

434

NHQ40

NOMESCO Finland

Amputation of toe

7.8

307.7

809

756

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.1

307.7

1604

1944

R53

ICD-10 Finland

Malaise and fatigue

2.0

307.7

6275

25128

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

5393

20989

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

6.0

307.7

4340

5851

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.8

307.7

9916

17231

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.3

307.7

1999

2060

I50.9

ICD-10 Finland

Heart failure, unspecified

793.3

307.7

20640

780

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

307.7

5305

17987

Angiography of the heart and coronary arteries

4.1

307.7

2789

5262

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

7714

34127

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.5

307.7

825

1089

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.3

307.7

2160

3789

M10.0

ICD-10 Finland

Idiopathic gout

3.7

307.7

1372

2729

AA1

Conventional CABG

5.0

307.7

826

1183

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.2

307.7

4688

9090

T90

ICPC

Diabetes non-insulin dependent

2.3

307.7

8324

31054

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.6

307.7

2049

3367

R50.9

ICD-10 Finland

Fever, unspecified

2.2

307.7

4187

14934

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

24.2

307.7

1273

388

N19

ICD-10 Finland

Unspecified kidney failure

7.1

307.7

1776

1874

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.2

307.7

2407

2241

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.6

307.7

2187

4567

TK810

NOMESCO Finland

Hemofiltration

19.2

307.7

368

137

XG466

NOMESCO Finland

Sleep oxymetry

3.9

307.7

1149

2132

Z49.0

ICD-10 Finland

Preparatory care for dialysis

32.2

307.7

480

107

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

307.7

2000

5379

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

307.7

4424

10708

I35.0

ICD-10 Finland

Aortic (valve) stenosis

4.3

307.7

2837

5096

A10BB12

ATC

glimepiride; oral

3.5

307.7

2802

6151

C09AA05

ATC

ramipril; oral

4.1

307.7

12190

31673

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

307.7

17622

64570

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

307.7

4257

13632

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.8

307.7

1613

3127

SPAT1263

SPAT

Sampling

1.7

307.7

10750

53121

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.9

307.7

2777

5506

N17.8

ICD-10 Finland

Other acute renal failure

9.0

307.7

609

487

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

4207

15725

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

4.6

307.7

1066

1695

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

7.5

307.7

993

969

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.4

307.7

916

1043

R60.0

ICD-10 Finland

Localized oedema

3.1

307.7

4320

11173

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

13.5

307.7

835

449

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

5.1

307.7

1114

1579

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

307.7

8349

37124

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.1

307.7

1827

4382

C08DB01

ATC

diltiazem; oral

3.4

307.7

2001

4362

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.4

307.7

2838

6397

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.4

307.7

11554

27501

I47.2

ICD-10 Finland

Ventricular tachycardia

11.0

307.7

1314

882

A12AA04

ATC

calcium carbonate; oral

17.8

307.7

745

303

I48.1

ICD-10 Finland

Persistent atrial fibrillation

8.6

307.7

2703

2432

C01BD01

ATC

amiodarone; systemic

13.7

307.7

2289

1278

C03DA01

ATC

spironolactone; oral

17.4

307.7

10151

6368

I42.8

ICD-10 Finland

Other cardiomyopathies

17.3

307.7

342

141

A10BH05

ATC

linagliptin; oral

4.3

307.7

2226

3922

TK800

NOMESCO Finland

Hemodialysis

15.7

307.7

1262

592

N02AA05

ATC

oxycodone; systemic

2.1

307.7

5628

21426

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

307.7

4575

12756

250, ,

Kela drug reimbursment

+∞

307.7

1639

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.7

307.7

2255

2566

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

307.7

4508

11781

Z49.1

ICD-10 Finland

Extracorporeal dialysis

28.9

307.7

746

187

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.9

307.7

4867

10183

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4.6

307.7

1025

1636

R04.0

ICD-10 Finland

Epistaxis

2.6

307.7

2580

7482

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

307.7

10298

48402

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.3

307.7

3486

5209

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

8.4

307.7

4543

4473

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

5277

19125

207

Kela drug reimbursment

Chronic arrhythmias

7.0

307.7

10222

15250

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.0

307.7

2634

2542

WX722

NOMESCO Finland

PEEP

3.7

307.7

1810

3651

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.9

307.7

5055

13870

C07AG02

ATC

carvedilol; oral

3.2

307.7

2222

5245

ZXE00

NOMESCO Finland

One hour or less

1.7

307.7

10160

49342

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

3.1

307.7

2059

4985

C10AA01

ATC

simvastatin; oral

1.9

307.7

14067

68420

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

307.7

3465

8021

C01AA05

ATC

digoxin; systemic

15.0

307.7

6150

3681

A10AD05

ATC

insulin aspart; parenteral

6.0

307.7

693

827

I49.5

ICD-10 Finland

Sick sinus syndrome

4.3

307.7

1654

2820

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

34.2

307.7

293

B01AF02

ATC

apixaban; oral

4.6

307.7

6719

12804

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.5

307.7

2155

2945

1CX08, ,

NOMESCO Finland

82.6

307.7

381

R02

ICPC

Shortness of breath/dyspnoea

3.6

307.7

5279

11931

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.8

307.7

1317

1665

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

307.7

3745

11100

I20.09

ICD-10 Finland

Unstable angina

3.2

307.7

2257

5210

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

32.8

307.7

335

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

307.7

4811

16643

Z49.2

ICD-10 Finland

Other dialysis

44.5

307.7

330

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.1

307.7

9978

19498

C07AA07

ATC

sotalol; systemic

3.9

307.7

1529

2873

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

7.6

307.7

1289

1241

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

307.7

2022

5385

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

9354

44603

K78

ICPC

Atrial fibrillation/flutter

5.3

307.7

4241

6511

N18.0

ICD-10 Finland

End-stage renal disease

29.5

307.7

549

134

137

Kela drug reimbursment

Uraemia requiring dialysis

30.9

307.7

385

N18.8

ICD-10 Finland

Other chronic renal failure

11.5

307.7

1351

866

R4110

NOMESCO Finland

Physiotherapy

1.8

307.7

7815

34854

A10AE05

ATC

insulin detemir; parenteral

4.1

307.7

1939

3493

H02AB06

ATC

prednisolone; systemic

2.2

307.7

14105

63833

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

307.7

1673

3926

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.0

307.7

3340

6454

A10BH01

ATC

sitagliptin; oral

2.5

307.7

3273

9974

M04AA01

ATC

allopurinol; systemic

4.5

307.7

6568

12731

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

307.7

3556

11719

GD1LA

NOMESCO Finland

9.5

307.7

892

686

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.5

307.7

1000

854

I48.2

ICD-10 Finland

Chronic atrial fibrillation

11.3

307.7

3132

2178

A10BB01

ATC

glibenclamide; oral

4.1

307.7

1559

2816

I50

ICD-10 Finland

Heart failure

69.2

307.7

2736

310

L28

ICPC

Limited function/disability (L)

2.4

307.7

5903

20216

SPAT1254

SPAT

Administration of medicine

2.6

307.7

4734

14564

C09AA02

ATC

enalapril; systemic

2.3

307.7

6884

24282

A08

ICPC

Swelling

4.2

307.7

1881

3338

K77

ICPC

Heart failure

50.5

307.7

1763

263

J01FF01

ATC

clindamycin; systemic

2.0

307.7

7625

31357

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.9

307.7

4189

8500

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.0

307.7

686

830

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.5

307.7

2352

3267

E86

ICD-10 Finland

Volume depletion

4.5

307.7

930

1498

K99

ICPC

Cardiovascular disease other

4.1

307.7

1069

1907

I48

ICD-10 Finland

Atrial fibrillation and flutter

8.0

307.7

13982

22595

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

3.1

307.7

1753

4165

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.6

307.7

1230

1976

WX892

NOMESCO Finland

Monitored bed care

3.9

307.7

3324

6552

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

28.2

307.7

1284

337

R06.0

ICD-10 Finland

Dyspnoea

4.3

307.7

11686

28661

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.2

307.7

2708

4950

I50.0

ICD-10 Finland

Congestive heart failure

904.0

307.7

9848

121

SPAT1262

SPAT

Handing over of treatment supplies

2.2

307.7

5729

20761

R03BB04

ATC

tiotropium bromide; inhalant

3.3

307.7

4184

9958

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.1

307.7

1421

2523

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

18343

103353

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

307.7

2524

7063

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.6

307.7

4526

10169

A06AD11

ATC

lactulose; oral

2.2

307.7

4628

16650

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.2

307.7

2337

4201

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

9.6

307.7

3821

3205

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

3.6

307.7

8609

21689

J96.1

ICD-10 Finland

Chronic respiratory failure

11.2

307.7

1298

853

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

7420

25237

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

307.7

2679

7861

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

17.8

307.7

840

342

ZXD05

NOMESCO Finland

Urgent procedure

2.7

307.7

9899

33436

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.7

307.7

3505

7427

XF404

NOMESCO Finland

Ambulatory ECG

3.7

307.7

3853

8266

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.8

307.7

786

974

K07

ICPC

Swollen ankles/oedema

4.3

307.7

1782

3059

V03AE01

ATC

polystyrene sulfonate; oral

14.8

307.7

658

321

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.7

307.7

2926

4796

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.1

307.7

12144

26129

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

1345

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

307.4

1271

2722

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

9.0

306.9

453

359

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.7

306.0

1120

2206

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

306.0

1512

3622

SPAT1216

SPAT

Assessment of functional ability

1.9

303.9

4642

18493

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

11.3

301.1

386

245

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

5.8

300.7

641

795

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.8

299.3

784

1184

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

296.8

8499

40828

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.9

295.7

757

1120

WX882

NOMESCO Finland

High dependency care

3.9

294.8

983

1808

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

292.6

7926

37480

C02EA02, ,

ATC

3.0

291.8

1471

3564

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

291.5

1750

4677

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

8.4

291.0

451

383

J01DB01

ATC

cefalexin; oral

1.8

290.8

21025

127289

B01AF01

ATC

rivaroxaban; oral

2.0

288.1

4068

15747

B01AC06

ATC

acetylsalicylic acid; oral

3.6

287.2

1094

2215

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

286.1

1597

4101

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

285.4

1418

3405

K92.1

ICD-10 Finland

Melaena

2.7

285.4

1767

4799

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.2

284.6

867

1486

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

284.5

4061

15773

I20.01

ICD-10 Finland

Unstable angina

3.5

284.0

1132

2364

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

12.7

281.5

337

189

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.6

281.1

777

1229

Z2446

NOMESCO Finland

Social worker

2.7

280.9

1691

4524

XF402

NOMESCO Finland

ECG with work load test

2.1

280.5

3381

12349

Z3226

NOMESCO Finland

Physiotherapist

1.9

279.5

4889

20305

H3601, E113,

ICD-10 Finland

5.8

277.1

587

723

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

275.6

2961

10341

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

274.3

3261

11842

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.7

272.7

1665

4486

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.6

270.6

736

1148

H3603, E113,

ICD-10 Finland

9.7

270.4

379

278

JN4AD

NOMESCO Finland

Body CT examination

2.1

270.0

3236

11782

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

269.8

2554

8466

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

266.7

9429

47488

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.8

266.3

687

1023

N05CF01

ATC

zopiclone; oral

1.6

265.7

8672

42811

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

12.8

264.9

316

176

G47.3

ICD-10 Finland

Sleep apnoea

1.7

264.7

6021

26999

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

264.6

6865

31922

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

8.9

264.1

393

315

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

19.2

263.8

262

V03AE03

ATC

lanthanum carbonate; oral

68.9

261.9

194

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.4

261.5

508

570

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.0

259.6

641

917

3025

Kela drug reimbursment

Calcium carbonate

19.6

259.6

256

Z2221

NOMESCO Finland

Medical doctor

1.7

259.2

6812

31755

N02BE01

ATC

paracetamol; systemic, rectal

1.9

259.0

23155

145597

AS2

Ventricular pacemaker insertion VVI (R)

13.5

258.8

300

158

C09CA01

ATC

losartan; oral

1.7

258.6

7308

34725

B01AE07

ATC

dabigatran etexilate; oral

2.9

256.3

1382

3476

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.5

256.1

1003

2068

J94.8

ICD-10 Finland

Other specified pleural conditions

4.9

255.0

652

963

R03DA04

ATC

theophylline; systemic, rectal

2.7

254.9

1585

4308

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

254.5

3249

12092

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.8

253.5

872

1640

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.6

253.2

697

1098

160

Kela drug reimbursment

exenatide

4.6

252.9

688

1073

E87.6

ICD-10 Finland

Hypokalaemia

3.3

252.6

1085

2378

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.2

252.0

1161

2660

J46

ICD-10 Finland

Status asthmaticus

4.0

251.6

831

1516

SPAT1301

SPAT

No procedures

1.6

251.5

8185

40254

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

125.0

251.2

176

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

251.1

2509

8494

PE1AT

NOMESCO Finland

Femoral artery PTA

5.9

249.9

519

626

H3600, E113,

ICD-10 Finland

6.1

249.8

503

587

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.0

247.5

814

1480

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

247.0

3614

14100

AN4

Balloon angioplasty and drug eluding stent

3.1

245.7

1204

2863

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.9

244.6

834

1558

J01MA02

ATC

ciprofloxacin; systemic

1.6

244.1

10454

54776

AS7

Arrhythmia pacemaker insertion VVI (R) S

53.1

243.5

187

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.6

243.3

932

1892

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

29.4

243.3

211

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

6.7

242.6

453

486

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

4.6

242.0

653

1011

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

242.0

3820

15279

TFP34

NOMESCO Finland

Electrophysiological investigation

3.3

239.4

1033

2270

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

11.6

238.6

300

184

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

237.0

2816

10190

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

236.7

1784

5331

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.5

235.7

1674

4861

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

9.3

234.9

338

258

WX730

NOMESCO Finland

Conventional respirator

4.8

234.9

612

919

AP2

Catheterization of the right side of the heart

20.4

233.8

227

A10AB04

ATC

insulin lispro; parenteral

3.8

233.7

803

1508

A10AD01

ATC

insulin (human); parenteral

5.4

233.2

529

698

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

4.5

232.7

643

1016

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.4

232.5

662

1073

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

5.1

232.2

566

800

A41.8

ICD-10 Finland

Other specified sepsis

4.3

231.7

677

1121

SPAT1251

SPAT

Organisation of medication

3.2

231.2

1034

2324

K28

ICPC

Limited function/disability (K)

3.9

229.3

784

1467

C08CA13

ATC

lercanidipine; oral

1.8

229.3

4132

17212

AS4

Physiological pacemaker insertion DDD (R)

5.3

228.7

536

730

R55

ICD-10 Finland

Syncope and collapse

1.9

228.1

3259

12587

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

227.6

2823

10370

TFJ02

NOMESCO Finland

Muscle biopsy of heart

39.6

227.4

184

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.2

226.1

451

521

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

21.3

225.9

216

A10BJ02

ATC

liraglutide; parenteral

3.7

225.5

819

1601

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

20.1

225.1

220

TK820

NOMESCO Finland

Peritoneal dialysis

36.5

224.7

185

C09AA01

ATC

captopril; oral

4.6

224.6

605

935

FL1AC

NOMESCO Finland

Left cardioangiography

4.3

224.5

661

1101

H3603, E103,

ICD-10 Finland

9.6

224.0

317

236

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

223.7

1603

4672

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

102.6

223.5

159

R04.2

ICD-10 Finland

Haemoptysis

2.9

222.5

1164

2874

C09CA03

ATC

valsartan; oral

2.0

222.2

2758

10130

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

221.6

1530

4379

J96.9

ICD-10 Finland

Respiratory failure, unspecified

9.8

221.5

309

225

SPAT1252

SPAT

Overall medication plan or its review

2.3

220.6

2031

6631

R95

ICPC

Chron obstructive pulmonary disease

3.2

220.1

1001

2273

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.5

219.8

617

988

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

10.1

219.2

300

212

UJF32

NOMESCO Finland

Coloscopy

1.6

218.4

7193

35230

C09BA02

ATC

enalapril and diuretics; systemic

2.1

217.0

2505

8951

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

9.2

216.1

315

245

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

214.5

3407

13612

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

214.3

1307

3510

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

213.7

2147

7264

H02AB07

ATC

prednisone; oral

1.8

213.5

3599

14654

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

12.3

213.1

260

151

C08DA01

ATC

verapamil; systemic

2.8

213.1

1250

3288

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

212.7

1210

3130

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

212.4

917

2014

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.6

212.3

573

887

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

212.1

3146

12286

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

212.0

9663

50881

SPAT1097

SPAT

Recording of ECG

1.8

211.7

4221

18083

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

210.6

3055

11840

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.3

210.5

489

660

K83

ICPC

Heart valve disease NOS

5.8

210.4

445

547

B01AF03

ATC

edoxaban; oral

3.5

210.2

808

1643

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

209.7

231

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

208.0

1890

6131

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.5

207.9

800

1628

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.8

206.8

731

1401

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

15.1

206.6

227

107

ZZA00

NOMESCO Finland

Split skin graft

3.2

206.2

929

2096

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

53.4

205.9

158

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

204.5

2591

9573

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

204.4

760

1510

Catheterization and pressure measurement of the left side of the heart

4.4

204.3

592

973

212

Kela drug reimbursment

Gout

3.8

204.2

708

1338

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

203.3

1948

6460

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

5.4

202.9

466

622

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.8

202.6

702

1326

NGQ20

NOMESCO Finland

Amputation of lower leg

10.8

202.4

266

176

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

202.1

2027

6848

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.5

202.1

786

1611

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

202.0

1237

3328

SPAT1234

SPAT

Support of social functional capacity

2.5

201.9

1455

4248

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

201.9

1638

5054

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

200.9

10843

58965

R33

ICD-10 Finland

Retention of urine

2.0

200.7

2494

9147

B03XA01

ATC

erythropoietin; parenteral

8.3

200.1

313

269

R18

ICD-10 Finland

Ascites

4.0

198.2

638

1140

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

5.3

197.5

461

625

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

197.4

18306

145154

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

7.1

195.7

346

348

NFQ20

NOMESCO Finland

Amputation of femur

7.6

195.4

325

303

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

31.8

195.4

166

WX213

NOMESCO Finland

Lower leg blockade

7.2

195.3

342

340

WW500

NOMESCO Finland

Blood transfusion

2.7

195.2

1203

3246

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.7

195.2

519

793

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.6

194.7

364

391

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

31.0

194.1

166

I42

ICD-10 Finland

Cardiomyopathy

68.1

194.1

144

AN3

Balloon angioplasty and metallic stent

3.1

192.2

926

2176

280

Kela drug reimbursment

Clopidogrel

4.5

192.0

535

851

K29

ICPC

Cardiovascular sympt/complt other

2.5

190.9

1372

3998

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.2

190.7

452

622

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

4.0

190.5

612

1092

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

190.4

1285

3631

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

190.1

1128

2983

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

189.5

1543

4765

SPAT1211

SPAT

Application of soft bandage

2.0

188.2

2273

8241

J01DA01

ATC

[U] cefalexin

1.5

187.9

14843

86605

AP3

Catheterization of the right and left side of the heart

20.7

187.5

181

I95.9

ICD-10 Finland

Hypotension, unspecified

4.4

187.2

542

890

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.0

187.2

467

674

WX740

NOMESCO Finland

Nitrogen oxide therapy

35.5

187.1

155

H05BX01

ATC

cinacalcet; oral

11.4

187.1

238

149

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

1429.7

186.5

208

H36.01

ICD-10 Finland

Diabetic maculopathy

5.3

186.4

434

587

R11

ICD-10 Finland

Nausea and vomiting

2.1

186.4

2064

7242

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

7.2

185.5

324

321

SPAT1104

SPAT

Monitoring of emergency patient

2.2

185.0

1821

6098

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.6

184.7

406

519

C08CA05

ATC

nifedipine; systemic

2.2

184.7

1732

5685

AB2

AVR bio, stent

8.6

184.4

280

231

N05CD07

ATC

temazepam; oral

1.8

183.5

3334

13844

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

183.4

1129

3043

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.2

182.5

363

418

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.4

181.5

740

1565

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

181.2

1786

5982

N18

ICD-10 Finland

Chronic kidney disease

5.9

181.0

375

451

A10AA01, ,

ATC

3.9

180.3

612

1138

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

14.6

180.0

201

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.3

179.9

280

239

E66.0

ICD-10 Finland

Obesity due to excess calories

6.1

179.6

360

418

N03AX16

ATC

[U] pregabalin

1.6

179.4

5708

27509

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

38.3

179.2

146

A10BJ06

ATC

semaglutide; parenteral

2.5

177.5

1249

3600

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

177.3

3313

13862

Z51.5

ICD-10 Finland

Palliative care

2.0

177.3

2388

8994

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

175.7

1534

4882

S76

ICPC

Skin infection other

2.3

175.5

1444

4477

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.9

174.7

958

2425

OAB43, ,

SPAT

0.4

174.6

853

15149

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.4

173.3

336

376

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.3

173.0

746

1636

3A064, ,

NOMESCO Finland

13.3

172.5

201

107

AP4

Myocardial biopsy

40.8

171.5

138

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

171.1

1734

5870

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

170.9

566

1033

S18

ICPC

Laceration/cut

1.4

170.9

11885

67200

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.8

170.8

443

662

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

79.9

170.2

124

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

26.8

169.7

151

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

169.6

767

1733

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.2

168.5

758

1707

J01CF05

ATC

flucloxacillin; systemic

2.3

168.2

1492

4778

M01AH05

ATC

etoricoxib; oral

0.7

168.0

10177

88853

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

7.6

167.2

278

259

XF409

NOMESCO Finland

Other special ECG

8.0

167.2

267

236

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

166.8

1375

4264

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.0

166.2

530

940

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

10.7

165.9

219

146

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

165.7

909

2301

M10.3

ICD-10 Finland

Gout due to impairment of renal function

13.1

165.1

194

105

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

7.0

164.7

293

297

U14

ICPC

Kidney symptom/complaint

4.3

164.0

477

786

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.4

163.6

675

1438

ZXA05

NOMESCO Finland

Left side

1.5

163.4

6493

32790

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

162.9

513

901

GD1UN

NOMESCO Finland

Lung circulation SPECT

9.2

162.8

237

184

J01CE08

ATC

benzathine benzylpenicillin; parenteral

5.2

162.8

387

534

A07AA09

ATC

vancomycin; oral

4.5

162.7

454

723

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

162.3

811

1946

T89

ICPC

Diabetes insulin dependent

2.9

162.0

885

2235

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

161.9

2028

7434

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

161.7

9249

50245

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

25.2

161.3

146

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.2

160.2

489

838

Catheterization and pressure measurement of the right side of the heart

15.0

160.1

176

FXG00

NOMESCO Finland

Insertion and use of IABP

20.4

159.6

155

C09AA04

ATC

perindopril; oral

2.2

159.3

1513

4984

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

8.2

159.2

250

216

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

158.8

175

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

158.0

1210

3628

A10BX07

ATC

[U] liraglutide

4.7

157.6

418

637

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

157.5

958

2564

H02AB04

ATC

methylprednisolone; systemic

1.7

157.5

3410

14846

321

Kela drug reimbursment

Paricalcitol and cinacalcet

10.2

156.6

213

149

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.4

156.3

631

1325

L17

ICPC

Foot/toe symptom/complaint

1.5

156.2

6917

35671

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

3.7

155.9

570

1118

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.3

155.9

463

776

WX002

NOMESCO Finland

Sedation and analgesia

1.6

155.3

5026

24206

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

154.7

11636

66303

Single vessel balloon catheter extension

3.2

154.0

703

1597

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

153.2

1089

3151

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

153.2

573

1142

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

152.5

5385

52410

B80

ICPC

Iron deficiency anaemia

3.4

152.3

612

1281

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

21.4

152.0

145

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

152.0

5441

26793

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.5

150.5

334

431

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.4

150.4

257

248

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

149.7

786

1940

PD5AD

NOMESCO Finland

CT of aorta

3.1

149.6

691

1581

XF622

NOMESCO Finland

Measurement of minute volume of heart

12.4

149.2

181

104

T92

ICPC

Gout

3.2

148.9

672

1516

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

148.6

1478

4959

AN2

Balloon angioplasty, including several vessels

2.8

148.4

865

2262

A10BH02

ATC

vildagliptin; oral

3.4

148.3

610

1297

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

147.8

1191

3653

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

50.5

147.2

114

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.2

147.0

450

773

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.1

146.9

201

142

ZXA00

NOMESCO Finland

Right side

1.5

146.9

6841

35557

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

6.7

146.5

272

290

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

146.0

1838

6741

B01AC07

ATC

dipyridamole; systemic

2.3

146.0

1283

4088

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

145.9

1643

5784

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

155.3

145.8

175

B82

ICPC

Anaemia other/unspecified

2.9

145.8

782

1954

L04AD01

ATC

ciclosporin; systemic

4.0

145.2

464

824

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

3.5

144.8

564

1156

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

144.5

817

2102

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

21.9

143.6

136

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

143.2

9687

53936

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

19.6

143.2

141

N30.0

ICD-10 Finland

Acute cystitis

1.7

142.7

3487

15646

R03BB01

ATC

ipratropium bromide; inhalant

2.4

142.7

1079

3214

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.8

142.6

489

916

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.4

140.9

402

652

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

140.9

995

2869

SPAT1260

SPAT

Consultation of another employee

1.6

140.8

4350

20671

C02DE04, ,

ATC

3.0

140.7

716

1736

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

4.1

140.4

443

779

AC4

MVP

9.1

140.3

205

160

ZXD00

NOMESCO Finland

Emergency procedure

2.7

140.2

826

2172

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

10.9

140.2

182

118

R03AC12

ATC

salmeterol; inhalant

2.3

139.5

1180

3697

SPAT1167

SPAT

Insertion of urinary catheter

2.6

139.2

936

2635

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

138.9

1177

3690

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

6.3

138.9

272

308

R06.2

ICD-10 Finland

Wheezing

2.4

138.5

1044

3105

SPAT1172

SPAT

Guidance concerning hydration

3.0

138.2

671

1582

A12AA12

ATC

[U] calcium acetate

61.4

138.2

104

A29

ICPC

General symptom/complaint other

1.7

138.2

3115

13675

162

Kela drug reimbursment

liraglutide

4.7

138.1

364

552

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

137.9

508

1002

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.1

137.8

424

731

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

5.1

137.8

335

472

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

137.8

2065

8033

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

3.8

137.6

466

865

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

137.2

415

706

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

13.4

137.0

159

C10AX09

ATC

ezetimibe; oral

1.6

136.6

4304

20531

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.7

136.0

360

548

E0000UV, ,

ATC

1.4

135.8

9305

51791

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

135.4

1433

4923

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.5

135.3

967

2804

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

18.8

134.8

135

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.1

134.6

425

748

R31

ICD-10 Finland

Unspecified haematuria

1.7

134.6

2924

12703

R60.1

ICD-10 Finland

Generalized oedema

8.6

134.5

205

170

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.7

134.0

290

365

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

8.2

133.5

210

182

N05BA04

ATC

oxazepam; oral

1.5

133.5

5802

29645

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

20.3

132.7

129

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

132.2

1974

7666

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

132.0

4520

21951

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

131.1

784

2078

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

131.0

1113

3492

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.7

130.9

805

2165

ZX108

NOMESCO Finland

Inhalation

5.8

130.4

273

332

C01BC04

ATC

flecainide; systemic

2.4

130.0

1047

3208

TGC00

NOMESCO Finland

Bronchial lavation

2.7

129.4

780

2076

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.7

128.8

341

519

J01CA04

ATC

amoxicillin; systemic

1.4

128.6

19175

120923

A02BC01

ATC

omeprazole; systemic

1.4

128.3

6667

35221

B01AB04

ATC

dalteparin; parenteral

2.1

127.7

1352

4643

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.6

127.7

349

546

N06AX11

ATC

mirtazapine; oral

1.4

126.1

7568

41023

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.5

125.7

491

1008

J01FA06

ATC

roxithromycin; oral

1.4

125.5

9068

50745

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.4

125.4

357

578

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

6.4

125.4

240

265

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

125.2

138

C02CA01

ATC

prazosin; oral

3.5

124.9

487

999

R03BA05

ATC

fluticasone; inhalant

1.6

124.7

3817

18048

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.8

124.4

319

472

5253

FHL

Cardiac lung machine

5.4

123.9

280

368

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.5

123.8

344

546

C10AA04

ATC

fluvastatin; oral

1.7

123.0

2438

10311

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

6.0

122.7

251

298

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.1

122.7

579

1342

WW200

NOMESCO Finland

Immunization

2.8

121.9

676

1720

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.1

121.8

578

1344

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

54.9

121.6

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.6

121.1

811

2277

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.3

121.0

1051

3328

I27.0

ICD-10 Finland

Primary pulmonary hypertension

23.3

120.8

112

I48.3

ICD-10 Finland

Typical atrial flutter

4.1

120.6

373

646

I11

ICD-10 Finland

Hypertensive heart disease

6.3

119.2

232

261

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

119.2

3851

18418

742, ,

NOMESCO Finland

13.7

119.2

137

A08AB01

ATC

orlistat; oral

5.7

119.1

256

320

Initial pacemaker installation

7.4

118.8

203

196

SPAT1325

SPAT

Vaccination

1.4

118.7

8476

47225

40199

ICD-8 Finland

Essential benign hypertension

3.2

118.3

529

1186

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.4

118.1

267

351

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

117.6

2322

9803

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

7.0

117.6

210

214

W19

ICD-10 Finland

Unspecified fall

1.7

117.1

2345

9939

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.4

117.0

265

349

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

116.9

544

1250

D64.8

ICD-10 Finland

Other specified anaemias

3.2

116.5

530

1201

N05AX08

ATC

risperidone; systemic

1.8

116.1

1890

7533

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

10.6

115.9

153

102

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.8

115.9

649

1660

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

4.3

115.8

343

574

SPAT1151

SPAT

Treatment of major wounds

3.9

115.7

384

702

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.3

115.5

484

1041

A10BX01

ATC

guar gum; oral

2.3

115.4

993

3131

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

13.8

115.2

132

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.9

114.5

603

1490

C02EA01, ,

ATC

4.2

114.4

349

598

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

6.6

113.9

213

229

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

113.6

3158

14569

I20.91

ICD-10 Finland

Angina pectoris, unspecified

3.6

113.3

414

812

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.1

113.3

541

1263

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.4

113.2

322

521

F05.9

ICD-10 Finland

Delirium, unspecified

2.9

113.1

607

1516

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.9

112.9

603

1502

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

112.2

839

2483

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.8

111.9

640

1656

WX890

NOMESCO Finland

Intesive care monitoring

5.4

111.2

250

327

R5110, ,

SPAT

1.9

111.2

1662

6445

N05BA01

ATC

diazepam; systemic, rectal

1.6

110.6

3008

13799

K90

ICPC

Stroke/cerebrovascular accident

2.4

110.1

819

2418

ZXA10

NOMESCO Finland

Bilateral

1.5

110.0

4556

22932

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

21.2

109.8

105

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

50.1

109.6

C10AA03

ATC

pravastatin; oral

1.8

109.5

1997

8233

A10AE06

ATC

insulin degludec; parenteral

2.5

109.4

760

2172

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

109.2

801

2349

C02DE02, ,

ATC

3.4

109.0

435

906

QDB10, ,

SPAT

3.1

109.0

500

1139

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

10.3

108.8

146

100

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

108.7

2235

9533

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

108.7

1458

5452

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

108.5

2176

9217

K65.0

ICD-10 Finland

Acute peritonitis

3.9

107.3

351

635

B01AC24

ATC

ticagrelor; oral

2.1

107.2

1088

3671

5315

FHL

Bypass surgery using a mammary artery

4.4

106.9

301

483

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

106.6

8530

48198

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.3

106.6

311

514

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.4

106.4

300

482

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

106.4

2297

9928

N25.0

ICD-10 Finland

Renal osteodystrophy

15.2

106.2

116

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

6.1

105.7

213

249

R28

ICPC

Limited function/disability (R)

3.7

105.4

382

745

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

38.0

105.3

I48.4

ICD-10 Finland

Atypical atrial flutter

5.5

105.3

233

300

WZC30

NOMESCO Finland

Teaching

1.5

105.1

3875

19023

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

45.2

105.1

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.1

104.6

1046

3508

R4180

NOMESCO Finland

Podiatric therapy

3.9

104.4

341

616

K08.3

ICD-10 Finland

Retained dental root

1.8

104.1

1915

7911

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

103.9

1465

5569

5CM18, ,

NOMESCO Finland

8.1

103.9

165

145

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

103.6

1047

3526

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

44.6

103.6

111

Conventional CABG

4.8

103.3

263

387

B01AB10

ATC

tinzaparin; parenteral

1.7

103.2

2374

10429

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.9

102.9

544

1347

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.4

102.3

291

471

M04AA03

ATC

febuxostat; oral

8.0

102.2

163

144

342

Kela drug reimbursment

Dronedarone

4.4

102.1

291

472

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

101.9

1469

5625

288

Kela drug reimbursment

Febuxostat

7.7

101.9

168

155

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

4.0

101.7

328

587

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

101.7

1172

4151

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

101.6

112

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

6.4

101.4

196

219

JN4BD

NOMESCO Finland

Extensive body CT

1.6

101.3

2784

12785

ZPB22

NOMESCO Finland

Autograft of vein

6.0

101.3

208

248

SPAT1060

SPAT

Administration of oxygen

7.7

101.3

166

152

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

100.9

4149

20812

R42

ICD-10 Finland

Dizziness and giddiness

1.4

100.8

5593

29681

I95.2

ICD-10 Finland

Hypotension due to drugs

5.1

100.8

243

340

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

170.0

100.7

120

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

11.6

100.5

126

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

100.4

1007

3381

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.7

100.4

262

394

A10AB06

ATC

insulin glulisine; parenteral

4.4

100.1

284

459

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.5

99.9

278

442

A10BX04

ATC

[U] exenatide

4.2

99.8

299

505

H25.8

ICD-10 Finland

Other senile cataract

1.6

99.8

3004

14092

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

4.6

99.6

268

414

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

99.6

701

2016

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

99.5

317

562

AC2

MVR bio

49.5

99.0

M86.6

ICD-10 Finland

Other chronic osteomyelitis

8.3

98.7

153

130

T82

ICPC

Obesity

2.5

98.7

682

1944

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.4

98.7

389

804

H26.4

ICD-10 Finland

After-cataract

1.6

98.5

2665

12187

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.7

98.5

599

1601

WX721

NOMESCO Finland

Oxygen concentrator therapy

11.6

98.2

123

I97.0

ICD-10 Finland

Postcardiotomy syndrome

7.7

98.0

162

150

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

97.4

596

1598

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.7

97.4

565

1473

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

97.3

2164

9416

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

12.9

97.3

115

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

97.2

1117

3951

N03AX12

ATC

[U] gabapentin; oral

1.5

97.0

3646

17943

QDA10

NOMESCO Finland

Incision of skin of lower limb

5.0

97.0

240

344

R81

ICPC

Pneumonia

2.2

96.9

892

2892

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

4.7

96.9

252

378

R03AC13

ATC

formoterol; inhalant

2.0

96.8

1148

4108

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

32.2

96.8

J43.9

ICD-10 Finland

Emphysema, unspecified

3.0

96.5

474

1125

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

8.5

96.5

148

124

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

14.4

96.5

108

UKC02

NOMESCO Finland

Cystoscopy

1.5

96.4

4370

22321

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

96.0

4148

20991

N05AH04

ATC

quetiapine; oral

1.5

95.9

3235

15556

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.5

95.7

364

734

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

29.4

95.7

R03BA02

ATC

budesonide; inhalant

1.5

95.7

3694

18277

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.8

95.5

525

1329

C07AB05

ATC

betaxolol; oral

2.4

95.4

724

2157

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

3.9

95.3

314

571

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.0

95.1

457

1071

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

95.0

6830

37791

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.4

95.0

386

814

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.5

94.9

211

273

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.0

94.8

470

1122

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

94.7

2382

10695

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

5.6

94.7

208

266

SPAT1310

SPAT

Counselling related to known health issue

1.4

94.7

7269

40633

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.1

94.6

189

219

E000001, ,

ATC

1.5

94.4

4024

20302

J45.8

ICD-10 Finland

Mixed asthma

2.4

94.4

699

2059

AB1

AVR mechanical

7.5

94.2

158

149

L04AX01

ATC

azathioprine; systemic

2.2

94.2

901

2967

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

94.1

2037

8797

FXZ00

NOMESCO Finland

Off-pump cardiac operation

5.1

93.8

223

308

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

6.6

93.7

175

188

R4190

NOMESCO Finland

Nutritional therapy

2.3

93.7

791

2472

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

93.5

2386

10751

OAA67, ,

SPAT

0.4

93.3

465

8293

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

93.2

496

1233

A10BB07

ATC

glipizide; oral

3.4

93.2

367

758

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.5

92.9

634

1796

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

92.2

1336

5122

RS221, ,

NOMESCO Finland

3.5

92.1

356

726

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

8.4

92.0

142

120

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

92.0

361

744

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.1

91.8

424

970

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

91.6

9163

53218

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.0

91.4

441

1036

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

90.6

603

1687

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.4

90.6

682

2024

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

7.9

90.5

146

131

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

3.2

90.3

397

881

5314

FHL

Bypass surgery for four or more vessels

5.0

90.2

221

314

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

90.1

2982

30017

L04AA01

ATC

[U] ciclosporin

3.4

89.6

359

750

S20

ICPC

Corn/callosity

2.6

89.4

556

1503

349

Kela drug reimbursment

Febuxostat

7.9

89.4

144

129

E05.89

ICD-10 Finland

Other thyrotoxicosis

8.6

89.2

135

111

AD1

TVP

27.6

88.4

A01

ICPC

Pain general/multiple sites

1.7

88.3

2000

8735

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.2

88.3

811

2626

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.8

88.3

306

578

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

88.0

617

1771

C01BD07

ATC

dronedarone; oral

4.5

87.9

245

390

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

87.5

1434

5713

SPAT1139

SPAT

Nutrition survey

2.3

87.5

741

2318

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

87.4

623

1802

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.8

87.4

183

223

M48.0

ICD-10 Finland

Spinal stenosis

1.5

87.3

3163

15420

K87

ICPC

Hypertension complicated

2.4

87.0

682

2062

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

11.2

86.9

111

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

86.9

1877

8096

E87.2

ICD-10 Finland

Acidosis

5.3

86.8

198

263

A10BJ05

ATC

dulaglutide; parenteral

2.8

86.6

474

1197

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

86.6

727

2266

K92.0

ICD-10 Finland

Haematemesis

2.5

86.4

609

1752

TFP35

NOMESCO Finland

Electroanatomical mapping

3.0

86.4

420

991

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

21.0

86.4

R03AC03

ATC

terbutaline; inhalant

1.5

86.1

2786

13253

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

7.0

86.0

152

153

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

85.9

4066

20888

R03BA01

ATC

beclometasone; inhalant

1.5

85.9

2991

14457

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.9

85.7

452

1118

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.4

85.7

350

741

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

85.6

497

1296

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

85.5

511

1353

SPAT1101

SPAT

Orthostatic test

2.0

85.5

1095

4025

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

15.3

85.4

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

84.9

1163

4374

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.5

84.7

232

364

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

84.6

1610

6704

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

84.2

501

1324

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.7

84.1

297

569

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

84.1

742

2363

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

46.7

84.0

E66

ICD-10 Finland

Obesity

2.2

83.8

815

2701

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

83.7

1550

6402

C08CA07

ATC

nisoldipine; oral

3.5

83.2

323

661

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

83.2

1623

6805

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

34.9

82.9

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.5

82.7

322

660

M01AB01

ATC

indometacin; systemic, rectal

1.6

82.7

1949

8595

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.9

82.6

430

1056

N06AB04

ATC

citalopram; systemic

1.4

82.2

4387

23011

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

82.2

273

500

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

4.7

81.9

217

331

A10BG02

ATC

rosiglitazone; oral

3.0

81.8

392

917

X57

ICD-10 Finland

Unspecified privation

2.5

81.7

546

1531

N05AA02

ATC

levomepromazine; systemic

2.1

81.4

859

2940

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

12.0

81.3

100

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

36.4

81.3

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

21.8

81.2

ZXE90

NOMESCO Finland

More than 22 hours

4.7

81.1

215

328

WX900

NOMESCO Finland

Resuscitation

5.6

81.1

175

220

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

15.0

81.0

H3601, E103,

ICD-10 Finland

4.7

80.9

213

323

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

80.8

938

3327

I13.1

ICD-10 Finland

Hypertensive heart and renal disease with renal failure

20.0

80.8

U04

ICPC

Incontinence urine

1.8

80.3

1260

4951

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

8.3

80.3

125

107

4029B

ICD-9 Finland

Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]

+∞

79.8

M10.2

ICD-10 Finland

Drug-induced gout

12.7

79.6

I15.0

ICD-10 Finland

Renovascular hypertension

7.0

79.3

141

143

RD210, ,

NOMESCO Finland

3.1

79.1

358

809

R06

ICPC

Nose bleed/epistaxis

2.4

79.1

601

1791

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.9

79.1

1069

4001

5AB14, ,

NOMESCO Finland

17.4

78.5

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.5

78.1

213

333

SPAT1281

SPAT

Other administrative function

1.7

78.1

1731

7509

315

Kela drug reimbursment

Clopidogrel

3.5

78.1

306

630

S17

ICPC

Abrasion/scratch/blister

2.6

77.7

498

1367

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

19.9

77.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

77.5

464

1230

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

77.5

1653

7099

D09AB01

ATC

zinc bandage without supplements; topical

2.6

77.0

475

1279

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.8

76.9

115

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.7

76.9

455

1199

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.9

76.8

193

281

C08CA10

ATC

nilvadipine; oral

2.5

76.7

519

1464

B04AB02, ,

ATC

2.6

76.6

502

1394

N02AC04

ATC

dextropropoxyphene; oral

2.0

76.6

914

3275

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

76.3

1880

8378

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

76.3

515

1451

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

76.2

9975

59635

I95.8

ICD-10 Finland

Other hypotension

5.6

76.1

164

206

348

Kela drug reimbursment

Roflumilast

7.6

75.6

125

116

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

75.3

951

3477

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

75.2

2627

12683

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

75.1

663

2111

J01AA02

ATC

doxycycline; systemic

1.3

75.0

18847

122058

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

74.9

8590

50451

SPAT1053

SPAT

Memory test

1.4

74.6

3912

20422

J45

ICD-10 Finland

Asthma

1.6

74.6

1998

9088

I13.0

ICD-10 Finland

Hypertensive heart and renal disease with (congestive) heart failure

+∞

74.3

WX902

NOMESCO Finland

External defibrillation of heart

6.1

74.3

148

171

A10AA03, ,

ATC

4.7

74.3

195

295

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.7

74.3

264

508

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

74.1

5734

31870

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

5.5

74.0

164

212

H3602, E113,

ICD-10 Finland

9.3

73.7

106

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

73.7

1382

5726

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.2

73.4

220

372

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

73.1

1332

5472

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

15.5

73.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

72.7

548

1627

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.9

72.7

183

267

M79.6

ICD-10 Finland

Pain in limb

1.3

72.5

8987

53259

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

2.9

72.5

375

918

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

72.4

1017

3855

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

72.4

2800

13800

SDA03

NOMESCO Finland

Periodontal treatment

0.8

72.4

5664

49709

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.1

72.3

339

783

J01XX08

ATC

linezolid; systemic

4.6

72.2

193

297

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.4

72.1

531

1560

AQ1

Conventional electrophysiological examination

3.2

72.1

320

715

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.5

72.1

512

1479

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.2

72.0

316

701

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.0

71.9

177

253

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.9

71.7

180

262

A10BG03

ATC

pioglitazone; oral

2.2

71.5

632

2014

RS222, ,

NOMESCO Finland

3.3

71.4

294

626

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

4.1

71.3

222

387

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

71.0

633

2024

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

70.9

4647

25154

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

70.8

774

2684

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.3

70.6

161

214

K76

ICPC

Ischaemic heart dis without angina

2.1

70.5

695

2316

OAA80, ,

SPAT

0.3

70.4

223

4940

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

70.4

690

2294

C10AA02

ATC

lovastatin; oral

1.9

70.2

1031

3964

RS220, ,

NOMESCO Finland

3.4

70.2

286

605

N06AA09

ATC

amitriptyline; systemic

1.6

70.1

2111

9861

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

2.8

70.0

389

991

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.3

69.2

159

213

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.4

69.1

280

590

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

8.8

69.1

103

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

5.7

69.0

148

185

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

68.9

2000

9262

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

68.7

2616

12844

C09AA03

ATC

lisinopril; oral

1.8

68.7

1165

4685

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.3

68.6

197

322

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

68.6

1346

5646

I20.0

ICD-10 Finland

Unstable angina

3.6

68.6

255

507

K72.9

ICD-10 Finland

Hepatic failure, unspecified

5.3

68.5

156

207

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

3.6

68.4

256

511

J04AB02

ATC

rifampicin; systemic

3.0

68.4

332

783

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.2

68.3

307

691

Initial installation of the atrial pacemaker

8.2

68.0

106

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020876) Protein [Mass/time] in 24 hour Urine

848

1284

4.78

323.01

2.6

2.3

1.64

1.02

g/24h

5.58

473

575

(3037756) Immunofixation for Serum or Plasma

1376

3009

3.35

322.61

1.5

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2104

5883

2.65

322.53

2.2

2.3

3.81

3.73

g/l

1.37

1905

5205

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2105

5899

2.65

321.20

2.2

2.3

7.62

7.36

g/l

8.25

1908

5210

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2103

5895

2.64

320.71

2.2

2.3

—

(3035880) pH of Pleural fluid

576

594

6.97

319.28

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2181

6246

2.59

318.77

7.1

4.3

1.78

1.60

10.73

2066

5868

(3005719) IgG [Mass/volume] in Serum or Plasma

2963

9786

2.28

318.32

2.8

10.66

10.54

g/l

0.51

2751

8909

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

989

1725

4.16

317.92

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1425

3249

3.21

312.79

1.6

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6640

18927

2.96

307.65

10.9

6.2

103.57

104.63

mmol/l

45.56

6634

18914

(3044640) Blood type and Crossmatch panel - Blood

10361

48206

1.84

307.65

3.6

2.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3926

9090

3.40

307.65

12.9

8.0

1.46

1.33

12.41

3899

9032

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3520

5712

4.85

307.65

1.8

1.5

1.58

g/l

0.04

3028

4769

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2872

5370

4.10

307.65

2.2

1.9

2.88

2.22

ug/l

0.61

2569

4737

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18343

40372

7.90

307.65

5.9

1.9

3120.96

574.65

ng/l

307.65

17286

33576

(3003434) Protein [Mass/volume] in Pleural fluid

1439

1428

7.45

307.65

1.6

1.3

27.28

38.15

g/l

125.88

1239

1340

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2235

4396

3.82

307.65

3.0

3.4

57.03

35.72

mg/l

3.06

1783

3583

(3042733) HLA Ab [Presence] in Serum

387

145

19.09

307.65

5.0

3.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

7238

16012

3.99

307.65

10.1

6.5

10.59

12.97

kpa

262.81

6896

15302

(3023368) Bacteria identified in Blood by Culture

13387

40113

3.69

307.65

6.2

3.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

19135

74095

3.83

307.65

34.7

11.3

1.56

1.24

inr

173.38

5869

20554

(3000991) Gas panel - Venous blood

5391

11286

3.96

307.65

12.3

6.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15038

59083

2.80

307.65

6.8

3.1

106.15

51.99

ng/l

3.74

12880

43075

(3013826) Glucose [Moles/volume] in Serum or Plasma

19024

91701

2.57

307.65

9.4

4.0

7.29

6.72

mmol/l

185.73

18406

85885

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4392

13776

2.49

307.65

2.3

2.2

0.19

0.21

g/l

83.12

4003

12835

(40760892) CBC W Ordered Manual Differential panel - Blood

14806

68395

2.17

307.65

8.4

6.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2003

3004

5.00

307.65

4.3

2.3

25.22

24.56

mmol/l

6.32

1965

2938

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1488

3113

3.51

307.65

4.4

2.7

2.21

1.30

mg/l

165.07

1345

2819

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1894

3956

3.56

307.65

2.0

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

8576

39516

1.78

307.65

6.5

3.5

73.73

90.01

307.65

8389

38624

(3006315) Basophils [#/volume] in Blood

15588

72945

2.20

307.65

7.4

5.5

0.04

e9/l

0.42

13730

61773

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2351

4872

3.63

307.65

3.2

2.0

545.01

535.67

ug/l

0.04

2264

4556

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4371

16526

2.03

307.65

2.9

2.7

9.71

9.47

umol/l

0.28

3868

14479

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2603

6491

3.02

307.65

6.1

3.1

48.48

47.39

1.24

2571

6426

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1116

1659

4.91

307.65

7.7

5.5

11.99

11.50

mg/l

2.46

1019

1531

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9454

18147

5.12

307.65

3.7

1.8

2.28

2.31

g/l

5.92

8928

16467

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17421

79801

2.53

307.65

8.2

6.1

13.38

11.74

umol/l

39.90

16770

75499

(3002030) Lymphocytes/100 leukocytes in Blood

14777

70270

2.07

307.65

8.2

5.9

22.22

27.81

307.65

14082

65131

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10459

47765

1.89

307.65

3.2

2.5

63.19

65.23

u/l

0.10

9801

43566

(3006504) Eosinophils/100 leukocytes in Blood

14586

68335

2.10

307.65

8.0

5.7

2.64

2.93

38.67

13893

63054

(3000850) Epithelial cells [#/volume] in Urine

8052

32847

2.04

307.65

3.6

2.4

5.23

4.70

e6/l

3.24

7399

29155

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2182

4256

3.85

307.65

2.9

3.4

7.18

4.92

ratio

0.29

172

361

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3753

8701

3.37

307.65

10.1

6.4

24.75

24.55

mmol/l

1.91

3618

8268

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3421

7529

3.53

307.65

1.7

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2945

6829

3.29

307.65

5.5

2.6

25.34

25.20

mmol/l

1.01

2864

6641

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3917

9069

3.39

307.65

13.2

8.1

0.62

0.68

11.24

3890

9019

(3031040) Bacteria [#/volume] in Urine by Automated count

18395

100863

1.90

307.65

6.5

4.3

1483.56

1397.43

e6/l

0.07

337

1382

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1595

3187

3.69

307.65

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3951

7862

3.98

307.65

5.7

2.7

2.46

1.50

mmol/l

32.65

3059

5765

(3026250) Tacrolimus [Mass/volume] in Blood

447

201

15.93

307.65

38.4

31.2

7.36

7.39

ug/l

0.06

406

175

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8997

29483

2.73

307.65

6.6

3.1

707.01

467.75

ng/l

1.57

8431

23771

(3020630) Protein [Mass/volume] in Serum or Plasma

4861

12068

3.25

307.65

2.4

2.6

64.62

67.16

g/l

75.19

4478

10828

(3024928) Oxygen saturation in Venous blood

1495

2603

4.23

307.65

4.6

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5373

12711

3.47

307.65

3.1

2.1

10.32

6.99

ug/l

10.11

4747

11038

(3027315) Oxygen [Partial pressure] in Blood

1647

2979

4.09

307.65

6.5

3.0

8.14

8.69

kpa

24.53

1613

2908

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8435

28782

2.55

307.65

2.8

1.6

1.49

1.34

mg/l

3.13

6963

22044

(3026782) Osmolality of Urine

7624

31694

1.97

307.65

3.9

2.7

505.86

564.27

mosm/kgh2o

113.01

6755

26889

(3027945) Reticulocytes/100 erythrocytes in Blood

6457

16345

3.35

307.65

2.9

2.3

1.98

1.68

78.80

5849

14221

(3002032) Base excess in Venous blood by calculation

5940

12272

4.10

307.65

6.1

2.7

2.21

1.82

mmol/l

9.10

5137

10390

(36304419) Bacteria [Presence] in Urine

9396

42680

1.85

307.65

4.3

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3526

12190

2.20

307.65

2.0

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1018

1689

4.38

307.65

1.6

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

9802

19854

4.90

307.65

3.7

1.9

11.26

13.54

umol/l

142.92

9280

18205

(1616796) Gas panel - Central venous blood

1768

2687

4.90

307.65

5.6

2.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15382

66723

2.46

307.65

7.0

4.2

32.87

35.57

g/l

307.65

14482

61399

(3018418) pH of Serum or Plasma

10792

46277

2.08

307.65

6.7

3.4

7.40

0.76

2516

8513

(3024354) Oxygen [Partial pressure] in Venous blood

4650

10429

3.59

307.65

5.0

2.5

4.62

4.52

kpa

1.88

4480

10121

(3002582) Erythrocytes [#/volume] in Urine

10752

48060

1.96

307.65

4.5

3.0

119.48

94.15

e6/l

0.64

8848

36404

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4106

8280

3.95

307.65

5.9

2.7

5.26

5.08

kpa

23.89

3945

7732

(3021960) Folate [Moles/volume] in Serum or Plasma

8876

36794

2.05

307.65

1.8

1.5

18.79

20.79

nmol/l

25.80

7839

30569

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9827

45746

1.81

307.65

3.7

3.1

42.32

34.66

u/l

4.34

9295

43033

(3014007) Fractional oxyhemoglobin in Arterial blood

3941

9143

3.39

307.65

13.2

8.1

92.47

94.47

53.33

3922

9126

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11047

48421

2.03

307.65

2.7

2.1

243.62

214.40

u/l

1.09

10414

45027

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8145

36963

1.79

307.65

3.4

2.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2170

5837

2.76

307.65

2.5

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

7822

29751

2.20

307.65

2.0

1.7

1239.13

1126.31

nmol/l

17.90

6127

21620

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6602

16829

3.34

307.65

4.8

4.3

262.04

241.15

u/l

17.11

6272

15855

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3949

9771

3.17

307.65

1.9

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3431

11489

2.27

307.65

2.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1088

1923

4.12

307.65

1.5

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4313

15761

2.11

307.65

5.3

3.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8527

23043

3.36

307.65

4.7

3.2

0.81

mmol/l

1.42

8054

21362

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2421

5806

3.13

307.65

1.4

1.5

12.09

17.23

u/ml

0.66

150

(3001604) Monocytes [#/volume] in Blood

15542

72709

2.20

307.65

7.4

5.5

0.67

0.60

e9/l

147.78

13687

61586

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9129

22211

3.87

307.65

2.3

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11574

34483

3.40

307.65

3.0

2.0

3.47

2.86

mg/l

81.70

10330

28594

(3014111) Lactate [Moles/volume] in Serum or Plasma

5324

12418

3.52

307.65

10.5

6.1

1.45

1.33

mmol/l

9.54

5178

12088

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5720

13486

3.53

307.65

11.4

7.2

119.25

122.53

g/l

21.09

5618

13108

(3018010) Neutrophils/100 leukocytes in Blood

14522

69204

2.04

307.65

7.8

5.6

62.27

56.92

307.65

13832

64096

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2012

5375

2.77

307.65

2.2

1.6

—

(3019069) Monocytes/100 leukocytes in Blood

14659

68739

2.11

307.65

8.4

6.0

9.02

8.84

8.54

13974

63522

(3018095) Leukocytes [#/volume] in Urine

11612

55168

1.85

307.65

5.2

3.5

131.33

103.64

e6/l

1.55

9175

39068

(40760888) Immunoglobulin light chains.free panel - Serum

1740

3237

3.98

307.65

3.1

3.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1253

2238

4.09

307.65

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1527

3056

3.68

307.65

3.1

1.9

125.44

132.76

g/l

17.55

1182

2096

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3274

3856

6.68

307.65

4.0

2.6

0.34

0.36

u/ml

1.93

2076

2085

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17164

78922

2.47

307.65

12.9

5.4

1.19

1.22

mmol/l

307.53

14739

66272

(3042936) Bacteria identified in Isolate by Culture

6797

19680

2.92

307.65

2.7

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7597

17013

3.99

307.65

9.4

3.7

1.11

0.99

mmol/l

183.82

7158

15648

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3190

7927

3.09

307.65

14.7

8.4

—

(3019198) Lymphocytes [#/volume] in Blood

15748

74602

2.18

307.65

7.6

5.6

1.72

1.94

e9/l

15.96

14052

64640

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1205

2370

3.71

307.65

8.2

4.2

1434.27

1387.02

iu/ml

0.02

254

286

(3012501) Base excess in Blood by calculation

1610

2975

4.00

307.65

6.6

3.0

3.10

2.30

mmol/l

16.51

1177

2003

(3012516) Albumin [Mass/volume] in Urine

10740

49220

1.90

307.65

4.0

3.0

393.17

396.61

mg/l

0.03

7929

30036

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14028

53132

2.80

307.65

4.3

2.4

182.04

160.79

ug/l

4.16

13145

47744

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3651

7369

3.89

307.65

12.4

8.4

24.58

24.25

mmol/l

5.70

3497

7164

(3022806) Fractional oxyhemoglobin in Capillary blood

995

1625

4.45

307.65

2.2

1.6

88.56

89.91

6.89

982

1596

(3023199) Leukocytes [#/volume] in Pleural fluid

1242

1316

6.93

307.65

1.6

1.4

2628.86

3528.82

e6/l

0.44

904

967

(3023520) Reticulocytes [#/volume] in Blood

5045

12274

3.34

307.65

3.0

2.4

74.12

66.73

e9/l

29.03

3919

9295

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6523

15118

3.70

307.65

2.2

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2686

6475

3.14

307.65

4.5

2.2

0.64

0.66

1.63

2671

6447

(3022096) Basophils/100 leukocytes in Blood

14292

66256

2.11

307.65

7.9

5.8

0.61

0.68

46.89

13615

61042

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15942

71769

2.39

307.65

11.8

4.9

1.19

1.22

mmol/l

292.18

14969

64305

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1659

2980

4.12

307.65

1.7

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1406

2808

3.67

307.65

1.5

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20831

120862

1.95

307.65

11.5

7.1

86.74

78.39

u/l

90.52

20068

112824

(3028026) IgM [Mass/volume] in Serum or Plasma

2500

7466

2.50

307.65

2.0

1.9

1.22

1.40

g/l

2.72

2294

6722

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13199

66791

1.77

307.65

2.4

1.9

90.80

95.19

pmol/l

21.11

7659

33621

(3020682) Albumin/Creatinine [Ratio] in Urine

11226

51993

1.90

307.65

4.7

3.5

23.34

4.47

mg/mmol

107.03

8037

31390

(3020779) Urea [Moles/volume] in Serum or Plasma

6531

10826

5.30

307.65

12.5

4.0

13.14

8.15

mmol/l

307.65

6258

10229

(3026008) Bacteria identified in Urine by Culture

11073

45875

2.19

307.65

4.0

3.0

—

(3019060) Gas panel - Arterial blood

4505

8883

4.09

307.65

6.1

4.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

2227

4887

3.41

307.65

5.9

3.8

1.43

1.37

mmol/l

1.65

2181

4819

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2814

1178

18.70

307.65

3.3

2.6

0.83

0.73

nmol/l

10.32

2255

820

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3928

9704

3.17

307.65

5.7

2.6

133.48

69.96

ng/l

171.44

3441

8124

(3026493) Urate [Moles/volume] in Serum or Plasma

9824

39192

2.21

307.65

4.0

2.4

4107.32

5371.07

umol/l

2.03

8572

33607

(3028308) Erythrocytes [#/volume] in Pleural fluid

1132

1189

6.97

307.65

1.5

1.4

56844.58

67735.73

e6/l

0.36

685

737

(3004119) Hemoglobin [Mass/volume] in Venous blood

3494

8642

3.13

307.65

5.4

2.6

122.65

131.91

g/l

83.94

3398

8457

(3028626) Oxygen [Partial pressure] in Capillary blood

1847

2658

5.19

307.65

4.2

2.8

7.82

8.20

kpa

14.70

1810

2592

(3022313) Gas panel - Capillary blood

2767

6084

3.46

307.65

6.3

2.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7242

16025

3.99

307.65

10.1

6.5

5.17

5.07

kpa

11.49

6916

15319

(3021901) Oxygen saturation in Capillary blood

1584

2172

5.40

307.65

3.8

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

911

1004

6.59

307.65

1.4

1.3

7.18

5.51

mmol/l

36.49

862

915

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1211

2258

3.91

307.65

1.6

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5960

12313

4.10

307.65

6.1

2.7

5.99

5.73

kpa

48.61

5787

11983

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2044

5561

2.72

307.65

1.9

1.8

35.49

39.37

u/l

10.01

1595

4921

(40767503) Oxygen content in Capillary blood by calculation

1605

2772

4.28

307.65

3.7

2.0

15.47

16.84

23.92

945

1349

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3336

5761

4.52

307.65

6.3

2.8

24.18

mmol/l

0.03

3261

5632

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

931

1013

6.68

307.65

1.4

1.3

344.49

662.22

u/l

2.54

885

964

(3004588) Protein electrophoresis panel - Serum or Plasma

3757

10339

2.82

307.65

2.3

2.4

—

(3020891) Body temperature

2393

5657

3.18

307.65

7.5

4.1

—

(3013115) Eosinophils [#/volume] in Blood

15884

75297

2.19

307.65

7.8

5.7

0.20

e9/l

0.38

14079

64612

(3028271) Lactate [Moles/volume] in Capillary blood

1194

2094

4.16

307.65

2.4

1.6

1.70

1.74

mmol/l

0.70

1173

2028

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13510

71260

1.68

307.65

3.7

2.4

—

(3009508) Creatinine [Moles/volume] in Urine

10836

50489

1.86

307.65

3.9

3.0

6.66

7.72

mmol/l

131.73

9040

41735

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2118

5091

3.10

307.65

2.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2236

4406

3.81

307.65

3.0

3.4

69.52

48.12

mg/l

5.56

1791

3581

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1530

3404

3.30

307.65

2.1

1.8

12.57

10.72

mg/l

5.03

1414

3148

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3542

8280

3.32

307.65

2.0

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

720

852

6.10

307.65

1.4

1.2

11.34

15.38

u/l

3.10

635

819

(3007853) Bacteria identified in Skin by Aerobe culture

5367

15671

2.77

307.65

2.4

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

1839

4226

3.22

307.65

6.6

3.9

3.99

3.87

mmol/l

14.30

1819

4199

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9188

16946

5.28

307.65

3.8

1.9

20.03

23.69

90.15

8022

14173

(40768806) Pleura Pathology biopsy report

1033

1234

6.10

307.65

1.6

1.5

—

(3016502) Oxygen saturation in Arterial blood

6581

14352

3.96

307.65

10.4

6.9

94.07

96.27

96.58

6362

13836

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3734

8375

3.49

307.65

10.9

6.1

25.01

24.76

mmol/l

2.68

3699

8300

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1881

4514

3.08

307.65

1.6

177.75

318.44

titre

1.76

209

(3003396) Base excess in Arterial blood by calculation

7203

16008

3.97

307.65

10.1

6.5

1.48

0.88

mmol/l

21.43

5907

12831

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6281

11211

4.85

307.65

4.9

1.9

421.45

96.66

ng/l

263.37

5954

10166

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1406

2808

3.67

307.65

1.5

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1607

2883

4.12

307.65

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6562

15114

3.73

307.65

2.2

1.6

—

(3010421) pH of Blood

1811

3453

3.89

307.65

6.5

2.9

7.42

2.13

1622

3171

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7380

23230

2.71

307.65

3.3

1.8

31.55

29.43

106.34

7160

22615

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2251

5430

3.10

307.65

7.0

2.9

25.10

24.81

mmol/l

3.43

2126

4942

(3009343) pH of Capillary blood

4052

8179

3.94

307.65

5.8

2.7

7.41

7.42

7.06

680

985

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1696

3561

3.52

307.65

3.6

2.3

3.70

3.60

g/l

1.55

1627

3395

(3045788) Cell count panel - Pleural fluid

963

999

7.01

307.65

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1877

3589

3.89

307.65

1.4

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1577

3637

3.19

307.65

1.4

10.95

14.57

iu/ml

0.77

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2761

6599

3.17

307.65

4.5

2.2

1.32

1.20

7.19

2744

6563

(3023183) Ammonium ion [Moles/volume] in Plasma

1557

2573

4.47

307.65

2.8

2.2

32.86

32.70

umol/l

0.08

1414

2297

(3013650) Neutrophils [#/volume] in Blood by Automated count

16975

85568

2.08

307.65

10.8

9.0

4.90

4.06

e9/l

269.52

15141

73622

(3013290) Carbon dioxide [Partial pressure] in Blood

1612

2975

4.00

307.65

6.6

3.0

5.09

4.94

kpa

7.12

1578

2905

(3012544) pH of Venous blood

6120

12825

4.06

307.65

6.1

2.8

7.37

7.40

3.18

(3012441) Differential panel - Pleural fluid

1107

1141

7.09

307.65

1.6

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

9875

44477

1.89

307.65

4.4

2.9

0.78

0.38

e6/l

23.08

8095

33438

(40758558) Short blood count panel - Blood

8064

37427

1.74

307.65

8.3

6.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1977

5491

2.66

306.50

2.2

2.3

10.19

10.33

g/l

0.54

1768

4764

(3007930) Methemoglobin/Hemoglobin.total in Blood

2127

6149

2.56

304.56

7.2

4.4

0.86

0.89

3.85

2017

5769

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1059

2019

3.81

302.66

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1059

2019

3.81

302.66

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3844

14370

2.03

301.13

2.0

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

18191

105605

1.66

299.92

6.2

4.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

399

275

10.37

296.18

30.4

30.1

111.47

131.58

ug/l

4.36

301

239

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1515

3737

2.97

291.41

3.9

2.1

86.51

90.26

7.23

1481

3553

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3309

11846

2.11

289.98

2.2

2.4

374.16

378.66

nmol/l

0.45

3046

10886

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1952

5549

2.60

288.59

2.2

2.3

3.16

2.88

g/l

24.35

1755

4866

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1412

3395

3.04

283.55

4.0

2.3

223.51

192.10

26.84

1358

3195

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

967

1816

3.86

281.88

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1659

4429

2.75

276.54

8.2

5.3

1.43

1.29

mmol/l

5.17

1508

3895

(3037522) Nuclear Ab [Titer] in Serum

4288

17147

1.91

274.90

1.4

1.3

486.37

533.22

titre

0.94

992

3563

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

640

868

5.30

274.37

1.5

1.3

14.44

11.69

u/l

13.32

614

842

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

832

1422

4.23

274.04

1.7

1.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

1084

2279

3.45

269.08

4.8

2.1

64.87

63.51

1.00

1078

2267

(3036489) Thrombin time

1740

4844

2.64

267.50

3.4

1.8

22.62

21.49

5.94

1619

4255

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1167

2585

3.28

267.47

1.2

83.64

171.93

titre

0.94

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

942

1805

3.78

267.04

3.5

2.3

2301.33

6433.12

u/ml

0.47

134

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1775

5028

2.60

263.59

2.3

2.5

0.81

1.09

g/l

1.99

1518

4225

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2279

7279

2.32

262.09

3.5

3.3

4.15

4.49

pmol/l

36.05

2063

6376

(3021589) Normoblasts [#/volume] in Blood

12404

66875

1.57

261.57

17.0

9.0

0.01

0.00

e9/l

1.64

10301

54740

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1192

2718

3.19

260.85

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

10240

53064

1.58

253.67

3.8

3.4

2.33

2.36

mmol/l

62.70

8890

45738

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1586

4353

2.67

250.24

2.1

2.3

0.06

0.03

g/l

0.76

1441

3937

(21494890) Protein electrophoresis panel - 24 hour Urine

773

1362

4.09

244.80

1.8

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1345

3440

2.85

241.87

1.7

1.5

0.24

g/l

0.68

1275

3247

(3017817) Protein [Mass] in Urine collected for unspecified duration

662

1042

4.57

240.70

2.2

0.43

0.22

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1004

2176

3.34

237.68

1.8

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1369

3573

2.79

237.21

1.7

1.5

1.15

1.18

g/l

2.62

1304

3390

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1616

4609

2.57

236.05

2.1

2.2

35.38

38.39

g/l

60.61

1420

3908

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1483

4050

2.67

235.95

2.1

2.4

0.00

g/l

0.89

1341

3648

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6011

27729

1.68

233.99

3.6

2.6

1.29

1.20

e6/l

0.35

3618

15794

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

741

1315

4.06

232.44

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

741

1316

4.06

232.21

1.6

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1458

3983

2.67

231.74

2.1

2.4

0.00

g/l

-0.00

1338

3637

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

990

2169

3.30

230.41

1.8

1.2

17.61

19.95

u/ml

0.17

(3024932) HLA-DR beta [Type]

314

226

9.90

226.75

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6941

33474

1.62

225.92

1.8

1.7

17310489.68

31712393.00

pmol/l

1.59

5725

26788

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11154

60059

1.53

224.48

2.7

2.1

75.69

79.70

nmol/l

36.00

9925

52389

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5628

25769

1.68

223.87

3.8

2.8

2.81

2.05

e6/l

5.89

3278

13928

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

908

1916

3.42

223.74

1.8

1.2

120.64

112.17

u/ml

1.00

194

442

(3024471) HLA-A [Type]

316

236

9.54

222.78

1.0

—

(3013512) EKG study

9443

49117

1.55

221.72

6.8

3.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

414

445

6.65

221.32

15.3

1.4

637.85

2095.75

mg/l

0.68

329

284

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

622

997

4.48

221.29

1.7

1.4

—

(3000012) Reticulocyte production index

959

2129

3.26

218.52

2.4

2.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

385

391

7.03

216.00

1.5

1.3

65.70

57.89

2.84

304

328

(3035350) Ketones [Presence] in Urine by Test strip

13082

73598

1.49

207.74

5.1

3.5

0.00

estimate

2.34

3144

14526

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

974

2260

3.12

206.61

1.2

1.4

39.84

37.57

u/l

0.19

872

1909

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

852

1817

3.38

206.47

1.4

1.2

299.93

271.12

u/ml

1.78

577

1085

(3017181) Myelocytes/100 leukocytes in Blood

3221

12814

1.88

204.83

4.6

3.9

1.00

0.96

0.37

1469

4308

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

887

1970

3.25

201.84

1.4

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

13162

74504

1.48

199.52

5.2

3.5

0.00

estimate

0.41

2783

13236

(3021601) Nitrite [Presence] in Urine by Test strip

13005

73643

1.47

194.97

6.7

4.7

0.00

estimate

1.08

2960

13556

(3023419) Bacteria identified in Sputum by Culture

944

2229

3.06

194.42

2.2

2.4

—

(40768446) Kidney Pathology biopsy report

294

244

8.58

192.78

1.8

1.3

—

(3037121) Protein [Mass/volume] in Urine

1564

4854

2.35

189.97

3.4

2.9

0.48

0.23

g/l

17.13

845

1964

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2157

7653

2.07

189.29

1.5

1.3

—

(3003181) Sodium [Moles/volume] in Urine

1015

2547

2.88

188.17

1.5

1.3

56.74

65.25

mmol/l

8.46

804

2050

(3002179) Metamyelocytes/100 leukocytes in Blood

2931

11625

1.87

187.03

4.5

3.8

0.76

0.67

1.03

1276

3680

(3013707) Erythrocyte sedimentation rate by Westergren method

18527

113045

1.50

186.24

5.6

3.9

19.95

11.93

mm/h

307.65

17273

103018

(3004451) EKG impression Narrative

447

633

5.05

182.90

1.4

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3206

13172

1.81

182.65

6.6

3.2

1.21

1.23

mmol/l

64.71

2965

11212

(3040151) Glucose [Moles/volume] in Capillary blood

722

1505

3.45

180.93

9.1

3.8

7.56

7.30

mmol/l

1.06

617

1234

(3019977) pH of Arterial blood

450

651

4.94

179.90

2.7

2.6

7.42

0.18

176

231

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3315

13838

1.79

178.94

2.8

2.4

41.48

47.71

u/l

0.43

2803

11837

(3021440) Promyelocytes/100 leukocytes in Blood

3012

12211

1.83

178.91

4.6

3.9

0.08

0.13

3.72

1269

3737

(3017569) Oxygen content in Arterial blood

417

569

5.23

177.48

2.3

—

(3015736) pH of Urine

10627

58566

1.46

176.96

4.6

3.3

5.72

5.80

0.73

238

3307

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

522

875

4.27

175.80

2.3

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1070

2870

2.70

175.35

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

512

849

4.32

174.75

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

902

2209

2.95

174.40

5.9

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1272

3734

2.47

174.00

2.4

2.2

204.98

76.10

ug/min

10.82

774

2118

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

624

1216

3.68

172.34

3.7

2.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

317

338

6.68

170.65

1.5

1.3

2.40

3.14

0.69

256

289

(3018572) Chloride [Moles/volume] in Blood

1147

3239

2.56

169.88

9.6

6.0

104.38

105.19

mmol/l

5.76

1057

2913

(3039000) Anion gap in Blood

1147

3239

2.56

169.88

9.6

6.0

11.61

11.06

mmol/l

5.39

1057

2913

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

390

530

5.25

166.69

2.2

1.9

88.15

101.39

7.51

383

498

(3042631) Mycobacterium sp identified in Specimen

859

2132

2.90

162.15

2.5

2.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

18038

110710

1.45

161.87

4.5

3.8

15.47

14.91

pmol/l

127.17

16488

98150

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

812

1959

2.98

161.01

2.3

2.1

31.88

33.09

9.73

801

1952

(3025159) Blasts/100 leukocytes in Blood

2812

11507

1.81

161.01

4.7

3.9

0.18

0.40

1.82

1071

3092

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

584

1142

3.66

160.47

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

584

1142

3.66

160.47

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

584

1142

3.66

160.47

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

869

2184

2.87

160.42

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1385

4430

2.27

156.37

4.9

3.0

—

(3034770) Mitochondria Ab [Titer] in Serum

1121

3258

2.49

156.34

1.2

852.92

919.29

titre

0.12

(3048929) Epstein Barr virus Ab [Presence] in Serum

988

2700

2.64

155.99

1.4

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

299

339

6.28

152.45

1.4

1.2

2.85

4.09

mmol/l

5.87

272

318

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1038

2943

2.55

152.27

1.4

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

136

24.72

149.32

2.3

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1112

3295

2.44

148.78

1.2

135.79

147.47

titre

0.13

114

257

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

475

844

4.02

148.57

1.6

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

277

306

6.44

144.58

1.5

1.3

18.63

24.42

2.02

243

277

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

274

299

6.52

144.57

2.0

1.4

21731.63

6614.29

e6/l

1.41

170

147

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

801

2046

2.82

143.50

1.3

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

178

108

11.70

142.44

1.6

1.3

120.28

107.03

ug/l

0.48

140

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

450

9817

0.31

140.22

1.7

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

292

355

5.85

139.52

2.2

1.5

1305.03

8698.06

e6/l

1.36

227

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

253

266

6.76

137.89

1.5

1.3

22.10

23.79

0.31

206

231

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2815

12033

1.73

137.56

4.0

2.5

49.23

68.14

ml/min/173m2

132.62

1482

4432

(3044242) Glucose [Moles/volume] in Arterial blood

380

605

4.48

136.20

2.3

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

423

741

4.07

134.75

1.6

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

520

1061

3.51

134.38

1.7

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

423

743

4.06

134.29

1.7

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

233

7.11

132.45

1.5

1.1

16.86

12.33

g/l

8.17

198

176

(3011397) Hemoglobin [Presence] in Urine by Test strip

6710

35330

1.45

132.17

4.7

3.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

313

438

5.09

129.74

7.8

5.3

25.27

25.16

mmol/l

0.14

280

396

(21494755) Public health laboratory ask at order entry panel

380

8707

0.30

129.74

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

582

1315

3.17

128.57

1.7

—

(3044927) Protein electrophoresis panel - Urine

612

1428

3.07

128.26

1.3

1.2

—

(3014891) Appearance of Pleural fluid

169

113

10.61

127.81

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

423

777

3.89

126.64

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

7460

40317

1.42

126.45

5.7

3.9

0.00

estimate

0.04

2648

13037

(40761535) Cells panel - Urine sediment

2932

13004

1.66

124.22

4.5

3.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

602

1422

3.03

123.59

1.7

1.6

—

(3044889) 12 lead EKG panel

17836

111473

1.38

122.39

6.9

3.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

387

691

3.99

120.29

2.5

2.1

22.37

36.51

umol/l

0.72

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5793

30120

1.45

119.89

3.1

3.2

2.48

2.46

mmol/l

25.53

4982

26375

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1215

4109

2.14

119.22

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

580

1374

3.02

118.49

1.2

58.57

66.89

u/l

0.97

526

1195

(3007164) IgA [Mass/volume] in Serum or Plasma

4844

24414

1.49

117.06

1.7

1.4

2.97

2.54

g/l

23.78

3140

13517

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15140

92532

1.35

116.74

4.2

3.0

77.67

51.32

u/l

111.77

14021

84427

(3004809) Band form neutrophils/100 leukocytes in Blood

838

2435

2.47

116.57

3.7

3.4

1.51

1.58

0.21

740

2149

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

246

302

5.79

116.49

9.3

6.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

17.35

116.22

4.8

5.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

180

154

8.29

115.53

1.5

1.3

12.78

11.25

0.23

(3036525) Urea [Moles/time] in 24 hour Urine

48.45

114.09

2.7

3.2

—

(3000494) Fungus identified in Specimen by Culture

3692

17657

1.55

113.79

1.7

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

204

210

6.90

113.24

1.5

1.2

30.13

25.21

g/l

3.17

178

159

(3033799) Differential panel - Peritoneal fluid

251

324

5.51

113.14

2.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

566

1368

2.96

111.73

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22974

151067

1.49

108.95

35.3

12.6

26.84

26.03

mg/l

3.71

21552

118038

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

413

838

3.51

107.61

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

220

262

5.96

107.27

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

212

244

6.17

106.70

1.1

—

(3045716) Anion gap in Serum or Plasma

345

620

3.96

106.36

3.0

2.4

9.31

9.86

mmol/l

1.77

337

604

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

255

357

5.08

105.70

1.3

1.2

37.11

416.85

ug/l

3.56

124

200

(3041918) Cholesterol [Moles/volume] in Pleural fluid

195

207

6.69

105.47

1.3

1.1

1.28

2.01

mmol/l

7.50

115

124

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

405

823

3.51

105.30

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

859

2655

2.32

104.38

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

330

584

4.02

103.80

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

213

261

5.79

101.09

9.3

6.4

—

(3044007) Cell count panel - Peritoneal fluid

223

290

5.46

99.82

2.2

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12386

74579

1.32

97.92

2.7

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

344

656

3.73

97.92

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

344

657

3.73

97.72

1.4

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

146

118

8.77

97.64

1.4

1.2

340.60

339.66

u/l

0.00

(3035947) Staphylolysin Ab [Units/volume] in Serum

328

609

3.83

96.85

1.2

1.1

3.35

3.22

iu/ml

0.08

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

253

6180

0.28

96.52

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

379

785

3.44

95.83

5.8

3.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

161

154

7.41

94.95

1.4

1.2

0.90

1.51

mmol/l

0.60

110

(3017704) Immunofixation for Urine

358

719

3.55

94.71

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

258

408

4.49

93.31

2.4

2.5

—

(3047189) Immunofixation for 24 hour Urine

323

612

3.76

92.78

1.6

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

682

2006

2.43

92.36

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

559

1492

2.68

92.14

3.4

3.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

221

308

5.09

92.10

6.3

5.3

68.51

72.77

1.26

181

254

(3025941) Bacteria identified in Stool by Culture

1719

7169

1.74

89.97

1.4

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

148

137

7.66

89.58

1.4

1.3

19.98

29.02

1.70

113

110

(40761536) Microorganisms panel - Urine sediment

2690

12605

1.56

89.13

6.0

3.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9612

56370

1.32

88.90

5.7

3.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1932

8390

1.67

87.17

3.7

2.6

0.38

0.26

e6/l

2.51

1903

8233

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

355

758

3.33

85.76

1.2

117.73

80.37

u/l

6.67

316

640

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

408

963

3.02

83.90

1.2

202.73

137.73

titre

0.68

172

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

407

962

3.01

83.50

1.1

1.2

275.00

113.43

titre

0.70

(3008037) Lactate [Moles/volume] in Venous blood

1007

3625

2.00

83.35

5.3

2.6

1.66

1.61

mmol/l

0.82

977

3553

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

590

1708

2.47

82.63

1.4

1.2

4.31

3.72

u/ml

0.53

290

744

(3014148) Varicella zoster virus Ab [Titer] in Serum

423

1033

2.92

82.05

1.1

—

(3021788) Differential panel - Synovial fluid

822

2758

2.14

81.98

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

111

10.08

81.48

1.2

1.1

8.54

8.83

mg/l

0.07

106

(3051611) Lipemic interference index of Serum or Plasma

554

1568

2.52

81.31

5.2

3.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

342

738

3.30

81.31

1.2

1.3

34.89

21.54

u/l

3.73

301

606

(1761868) Lipid panel - Serum or Plasma

5453

48702

0.74

80.72

3.8

3.1

—

(3000492) Spirometry study

2698

12926

1.52

80.40

1.7

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

308

626

3.50

80.14

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

308

626

3.50

80.14

1.5

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

130

118

7.80

79.91

1.5

1.3

72.66

71.13

0.15

109

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

245

424

4.10

79.40

2.2

180.61

157.60

3.37

230

398

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

334

721

3.30

79.37

3.3

4.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

883

3090

2.05

78.92

1.5

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

134

130

7.30

78.19

1.3

1.2

6.68

253344.58

nmol/l

0.72

113

105

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

594

1774

2.39

77.83

1.4

1.2

5.51

3.86

u/ml

0.71

220

599

(3012565) Volume of 24 hour Urine

309

645

3.41

77.30

2.4

2.0

1685.78

2054.74

6.01

268

559

(4200892) Spirometry reversibility

2386

11218

1.55

77.29

1.5

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

31.11

77.17

4.5

1.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

116

8.47

75.78

1.1

14.86

20.53

g/l

6.90

111

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

325

712

3.25

75.49

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

325

712

3.25

75.49

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

324

709

3.25

75.40

14.7

6.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1009

3765

1.92

75.28

1.7

1.6

21570.84

12237.05

e6/l

4.15

719

2741

(3008757) Leukocyte morphology finding [Identifier] in Blood

554

1629

2.43

75.07

4.4

3.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1023

3851

1.91

74.34

1.8

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

116

100

8.21

74.13

1.2

1.1

15.97

24.53

u/l

2.66

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20928

137680

1.32

72.45

5.7

4.5

2.14

2.13

mu/l

0.04

19320

122952

(40768797) Stomach Pathology biopsy report

4099

21677

1.39

72.23

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

282

585

3.43

71.24

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

436

1186

2.62

69.32

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

360

4.14

68.94

3.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

360

4.14

68.94

3.0

2.4

—

(3004775) Volume in Urine collected for unspecified duration

451

1262

2.55

67.78

2.5

2.1

726.55

653.97

2.35

309

820

(3014271) Vancomycin [Susceptibility]

327

770

3.02

67.58

3.4

2.7

—

(3019225) pH of Specimen

3238

16648

1.42

66.58

7.6

3.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

139

171

5.76

65.85

1.3

1.2

607.73

185.10

ng/l

0.37

102

114

(3016750) Collection duration of Urine

352

878

2.85

65.84

2.4

1.9

498.83

500.41

min

0.09

257

636

(3016650) Hepatitis A virus Ab [Presence] in Serum

599

1933

2.21

65.74

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

291

650

3.18

65.61

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

917

3475

1.89

65.26

5.6

2.7

8.03

7.54

mmol/l

4.64

891

3414

(3041354) Potassium [Moles/volume] in Venous blood

616

2021

2.18

64.94

3.7

2.0

4.17

4.04

mmol/l

8.01

607

2005

(3035285) Chloride [Moles/volume] in Venous blood

615

2021

2.17

64.58

3.7

2.0

105.28

105.69

mmol/l

1.14

606

2005

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

107

102

7.42

63.37

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

345

871

2.82

63.16

1.5

1.4

16.29

12.61

umol/l

13.21

334

817

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

543

1722

2.25

62.13

1.1

1.66

1.50

g/l

12.80

503

1538

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

636

2152

2.11

62.05

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

602

1998

2.15

61.68

3.8

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

307

749

2.91

59.76

2.2

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

358

951

2.68

59.65

1.1

1.2

—

(3003129) Base excess in Capillary blood by calculation

189

335

4.00

59.51

2.2

1.5

1.10

0.35

mmol/l

1.25

175

316

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

969

3849

1.80

59.42

1.6

1.5

10.86

2.49

iu/ml

0.66

243

886

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

115

129

6.31

59.40

4.5

4.0

54.50

44.03

ug/min

0.74

105

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

15.91

58.86

1.2

1.0

5232.36

550.94

ng/l

3.00

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

119

140

6.02

58.85

2.3

132.67

45.19

mg/l

1.33

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

599

2024

2.11

58.66

1.1

—

(3044941) Cell count panel - Synovial fluid

662

2329

2.03

58.28

1.5

1.4

—

(3012898) Urea [Moles/volume] in Urine

8.53

57.87

1.3

139.67

209.65

mmol/l

4.07

(40762365) Oxygen content in Arterial blood by calculation

152

232

4.64

57.45

2.3

3.7

14.73

14.69

ml/dl

0.04

139

227

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

428

1267

2.41

57.23

1.3

1.1

89.97

97.75

5.87

412

1156

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

394

1129

2.48

56.46

2.6

2.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

480

1506

2.27

56.34

3.5

3.4

62.00

55.71

6.84

408

1250

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

15.40

56.18

12.5

4.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6569

38365

1.27

56.13

5.0

3.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1159

4928

1.69

56.03

1.2

1.49

0.81

u/ml

0.85

107

442

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

405

1182

2.44

55.84

1.9

1.8

5.36

3.42

mg/l

9.66

380

1124

(44816559) Phosphatidylethanol [Mass/volume] in Blood

600

2080

2.06

54.97

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

557

1879

2.11

54.79

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

237

522

3.22

54.72

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

464

1456

2.27

54.46

1.3

276.01

278.62

mosm/kgh2o

1.21

356

1126

(3016038) Potassium [Moles/volume] in Urine

354

980

2.57

54.45

1.2

33.28

35.02

mmol/l

0.67

311

831

(21494434) Karyotype in Bone marrow

452

1403

2.29

54.40

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

544

1828

2.12

54.05

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

510

1671

2.18

53.98

1.3

1.1

101.69

118.84

17.15

480

1461

(3024522) Salmonella sp identified in Specimen by Organism specific culture

546

1839

2.12

53.93

1.5

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

451

1412

2.27

53.22

2.1

8.18

7.21

titre

0.05

(3019150) Specific gravity of Urine by Refractometry

5598

32228

1.28

53.15

5.7

3.9

1.02

kg/l

1.08

887

4900

(3034426) Prothrombin time (PT)

186

357

3.69

52.68

1.4

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

167

3694

0.31

52.51

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

213

451

3.35

52.30

1.7

18001.18

23811.72

u/ml

0.10

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

316

843

2.66

52.28

1.6

1.5

8.07

6.88

u/l

0.55

251

669

(3025468) Yersinia sp identified in Specimen by Organism specific culture

535

1810

2.11

52.25

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

535

1816

2.10

51.81

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

534

1814

2.10

51.61

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

245

572

3.04

51.49

2.0

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1581

7413

1.54

51.09

1.3

287.94

266.42

u/ml

0.31

1463

6778

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

555

1929

2.05

50.51

1.5

68.34

57.13

8.73

362

1219

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

242

568

3.02

50.42

2.0

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

241

568

3.01

49.87

2.0

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

759

2954

1.84

49.69

2.5

1.4

1.02

0.77

nmol/l

9.92

596

2479

(3024980) IgG subclass 4 [Mass/volume] in Serum

587

2109

1.98

48.80

1.4

1.6

0.77

0.86

g/l

0.77

430

1557

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1478

15318

0.66

48.75

1.3

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

368

1098

2.38

48.44

1.5

1.6

23.02

26.17

u/ml

0.49

254

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

104

6.33

48.23

1.2

104.60

96.30

ug/l

0.19

(3001019) Free T4 and TSH panel - Serum or Plasma

245

4320

0.39

47.40

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

508

1761

2.05

46.59

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

934

3940

1.70

46.43

1.3

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

493

1697

2.07

46.07

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

941

3991

1.69

45.85

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

939

3983

1.69

45.73

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2728

14475

1.37

45.35

1.9

1.7

1.72

1.53

22.95

2247

12383

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

273

730

2.65

45.04

2.1

2.2

86.46

54.64

ug/min

0.79

161

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.74

44.99

2.6

1.6

65.37

56.50

0.93

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

123

195

4.47

44.59

1.5

1.1

76.23

73.36

0.24

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

707

2786

1.81

44.48

1.2

5.55

8.65

u/ml

0.22

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

135

232

4.12

44.35

7.9

6.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

693

2729

1.81

43.70

1.2

7.88

5.02

u/ml

0.35

215

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

166

339

3.47

43.12

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

211

502

2.98

43.04

1.5

1.9

75.31

124.86

umol/l

2.58

114

253

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

122

198

4.36

43.02

1.5

1.1

81.70

85.17

0.31

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.18

42.19

1.6

1.7

46.07

40.58

umol/l

0.72

(3011985) Renin [Units/volume] in Plasma

528

1931

1.95

41.78

1.3

1.4

89.12

58.91

mu/l

1.95

454

1720

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

776

3206

1.73

41.59

1.2

1.3

3.49

5.85

u/ml

0.78

341

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

782

3248

1.72

41.12

1.2

1.3

7.11

6.52

u/ml

0.13

131

522

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3331

18482

1.31

40.60

3.1

4.3

14.76

27.03

ug/l

3.16

2792

15261

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

305

911

2.38

40.14

1.3

130.00

63.26

titre

0.49

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

205

500

2.91

40.10

3.4

1.7

56.29

444.93

ug/l

1.08

196

468

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

419

1432

2.08

39.95

1.5

1.4

18.79

31.13

12.77

279

869

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

825

3505

1.68

39.94

1.2

28.79

41.54

u/ml

0.74

200

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

254

700

2.57

39.56

1.1

40.59

23.34

u/l

2.56

228

612

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

598

2323

1.83

39.43

1.6

1.9

20.56

23.88

ug/l

1.18

573

2283

(3045142) Bone marrow Pathology biopsy report

509

1876

1.93

39.40

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

301

904

2.36

39.15

1.0

1.1

309.68

280.95

mg/l

7.70

275

802

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

311

948

2.33

39.14

1.3

625.00

375.36

titre

0.44

(3011412) CD3 cells [#/volume] in Blood

385

1287

2.13

38.88

2.1

2.4

0.95

1.20

e9/l

2.57

351

1169

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

251

700

2.54

38.19

1.2

1.1

106.63

81.87

u/l

2.19

225

616

(3052592) Norovirus Ag [Presence] in Stool

131

247

3.75

38.17

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

159

345

3.26

37.75

1.3

1.7

—

(40757373) Influenza virus identified in Isolate

133

256

3.68

37.67

1.5

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

376

1262

2.12

37.60

1.7

1.3

23.65

23.55

iu/ml

0.01

(3028192) IgG subclass 2 [Mass/volume] in Serum

383

1303

2.09

36.99

1.4

2.64

3.06

g/l

3.88

259

879

(3027135) IgG subclass 1 [Mass/volume] in Serum

382

1302

2.08

36.73

1.4

7.39

6.86

g/l

1.09

255

882

(3024139) IgG subclass 3 [Mass/volume] in Serum

382

1302

2.08

36.73

1.4

0.50

0.42

g/l

1.13

260

878

(4062490) Immunoglobulin typing, IgG

381

1302

2.08

36.38

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

376

1284

2.08

35.98

1.2

1.3

1.64

1.33

nmol/l

4.95

335

1174

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1032

4757

1.55

35.85

1.4

254.76

265.28

ug/g

0.64

668

2795

(21491868) Cryoglobulin [Mass/volume] in Serum

177

424

2.96

35.78

1.3

1.2

0.26

0.92

g/l

1.18

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

65.02

35.60

5.8

8.6

430.39

326.40

umol/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

413

1467

2.00

35.55

1.5

1.3

156262.71

114601.16

e6/l

0.49

290

1014

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

6.56

34.92

2.4

1.5

12.55

17.47

0.46

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1724

8843

1.40

34.82

2.5

2.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

595

2413

1.76

34.07

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

173

422

2.90

33.92

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

461

1741

1.88

33.25

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

291

931

2.22

32.83

2.0

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

661

7493

0.61

32.52

1.3

—

(3045414) Leukocytes [Presence] in Urine

1346

6689

1.44

32.40

2.3

1.8

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

44.36

32.21

5.7

7.1

1.63

1.70

g/l

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

59.37

32.16

9.6

7.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

158

379

2.95

31.92

1.4

1.5

19.29

15.28

pmol/l

2.28

131

309

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

316

1058

2.12

31.88

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

317

1064

2.11

31.78

1.6

1.3

1.11

1.40

promille

2.83

246

815

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

470

1814

1.84

31.71

1.2

1.3

311.49

332.34

pmol/l

0.14

384

1547

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

690

2981

1.65

31.39

1.6

1.7

4.12

7.86

iu/l

0.60

211

962

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

498

1974

1.79

30.84

2.2

2.5

112.85

1330.23

u/ml

1.73

485

1948

(3044416) Complement C4 [Mass/volume] in Pleural fluid

7.35

30.71

1.2

1.1

0.05

0.09

g/l

2.31

(3008116) Ketones [Moles/volume] in Urine by Test strip

121

252

3.40

30.68

1.4

1.3

—

(3036603) Volume of Urine

284

927

2.17

30.56

1.5

1.6

1841.85

1888.76

0.40

277

890

(3009466) Valproate [Moles/volume] in Serum or Plasma

472

1861

1.80

29.76

4.8

4.4

348.66

351.29

umol/l

0.15

410

1547

(3049717) Cytology report of Urine Cyto stain

1447

7399

1.40

29.68

2.6

2.8

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

100

5.02

29.52

1.1

1.0

11.53

21.29

iu/ml

0.55

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

232

3.45

29.29

1.6

1.5

—

(3022621) pH of Urine by Test strip

1850

9869

1.35

29.17

3.8

2.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

177

478

2.62

28.85

4.3

3.5

58.64

50.95

4.03

171

464

(3048879) Bone marrow aspiration report

168

445

2.67

28.43

1.5

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

237

740

2.27

28.39

4.2

3.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

407

1559

1.85

28.18

1.2

53.01

58.82

u/ml

0.16

108

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

108

222

3.44

27.97

1.1

3.99

3.32

pmol/l

0.11

(3002621) Streptococcal DNAse B [Units/volume] in Serum

100

4.88

27.84

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4700

28243

1.21

27.65

1.3

1.2

1.72

1.86

u/ml

0.27

1152

7003

(1175426) CD3 cells/100 lymphocytes in Blood

293

1008

2.06

27.62

1.9

2.1

72.15

70.89

0.55

274

963

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.45

27.56

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

287

988

2.06

27.02

1.9

2.1

15.38

16.87

1.33

274

960

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

132

315

2.97

26.99

1.2

1.1

75.25

88.14

3.51

153

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21306

144566

1.19

26.82

8.7

5.9

44.25

39.85

mmol/mol

307.65

19831

131318

(3027923) C peptide [Moles/volume] in Serum or Plasma

233

746

2.21

26.35

1.3

1.38

1.15

nmol/l

1.58

167

579

(3010503) CD19 cells [#/volume] in Blood

260

873

2.11

26.14

2.2

2.6

0.46

0.40

e9/l

0.07

245

846

(3006922) Hepatitis E virus Ab [Presence] in Serum

250

827

2.14

26.10

1.1

—

(3000330) Specific gravity of Urine by Test strip

1574

8330

1.35

26.09

4.7

3.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

131

318

2.92

26.03

1.2

89.39

104.21

2.88

123

295

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

870

2.11

26.02

2.3

2.5

447.13

560.40

e6/l

1.52

216

733

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

370

1415

1.86

25.79

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

106

228

3.29

25.67

2.1

3.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

449

1824

1.75

25.67

1.3

—

nmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3906

23229

1.22

25.30

1.3

42.56

38.06

iu/ml

0.85

1285

7179

(3032057) Clostridioides difficile [Presence] in Stool

123

293

2.97

25.26

2.1

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

460

1903

1.72

24.69

1.2

1.3

153.30

209.52

miu/ml

1.79

714

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

495

2091

1.68

24.62

2.8

1.9

25.19

27.30

mg/l

0.35

135

529

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

232

763

2.15

24.61

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

232

765

2.15

24.46

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

121

292

2.93

24.32

2.4

7.47

7.63

mmol/l

0.14

184

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

177

521

2.41

24.27

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.14

23.95

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

495

2109

1.67

23.85

1.3

0.16

0.24

nmol/l

1.50

153

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

271

958

2.01

23.82

2.3

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

318

1191

1.89

23.67

1.8

2.2

39.89

36.22

3.43

304

1172

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

494

2108

1.67

23.67

1.3

2.86

1.87

nmol/l

0.18

467

2026

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

184

3.46

23.57

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

461

1937

1.69

23.41

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

243

831

2.07

23.36

2.4

2.6

0.21

0.25

e9/l

2.10

216

728

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

142

3.83

23.30

2.2

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

139

3.86

23.25

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

381

1521

1.78

23.17

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

350

1363

1.82

23.09

1.2

1.1

1.10

2.02

iu/ml

—

(3004616) Nuclear Ab [Presence] in Serum

409

1671

1.74

22.98

1.2

1.3

—

(3028433) Virus identified in Specimen by Culture

162

470

2.44

22.95

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1805

9929

1.30

22.83

3.8

2.9

6.20

5.03

e9/l

1.95

1330

7591

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.59

22.74

6.4

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

139

376

2.62

22.70

1.8

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

267

957

1.98

22.62

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

313

2.78

22.55

1.2

70.55

88.16

3.98

158

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5189

41658

0.85

22.49

2.9

3.2

0.78

ug/l

0.05

3753

28842

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

174

3.45

22.24

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

317

1215

1.85

22.02

2.0

1.9

2.05

2.60

u/field

0.80

131

484

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

172

524

2.32

21.93

2.3

2.0

77.26

49.68

ug/l

2.05

165

512

(3024263) Appearance of Synovial fluid

232

800

2.05

21.86

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1054

5396

1.39

21.45

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

270

997

1.92

21.03

2.1

2.5

549.78

680.32

e6/l

1.52

247

957

(3014051) Protein [Presence] in Urine by Test strip

808

3963

1.45

20.88

3.1

2.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

544

2455

1.57

20.85

1.2

68.67

44.81

u/ml

2.02

248

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

199

661

2.13

20.69

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

111

282

2.78

20.46

1.8

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

951

4828

1.40

20.34

1.7

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

111

283

2.77

20.33

1.8

2.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

5.06

20.25

1.2

1.4

132.43

2713.59

u/l

1.24

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

330

1316

1.78

20.21

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

241

3135

0.54

20.04

1.3

—

(4035726) Immunohistochemistry procedure

2565

14976

1.23

19.56

1.6

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

173

556

2.20

19.54

1.1

1.2

154.42

168.71

mmol/24h

1.19

173

556

(3010838) Calcium [Moles/time] in 24 hour Urine

556

2564

1.54

19.41

1.7

1.9

4.00

5.19

mmol/24h

13.38

482

2217

(3034891) Synovial lining cells/100 cells in Synovial fluid

206

714

2.04

19.22

1.4

3.03

4.23

0.59

139

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

210

3.00

18.71

1.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

134

393

2.41

18.65

1.6

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

153

3.37

18.52

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

464

5018

0.65

18.52

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

718

2.01

18.29

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

596

6104

0.68

18.09

1.6

1.7

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

6.66

18.05

5.3

6.4

1.05

1.09

mg/l

0.04

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

196

3.03

18.01

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

154

491

2.22

17.78

1.2

1.1

3.29

25.12

u/ml

1.24

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

35.29

17.78

1.2

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

180

614

2.08

17.57

3.7

2.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

218

799

1.93

17.46

2.4

2.8

39.09

37.16

0.69

126

441

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

282

1123

1.78

17.43

1.2

42.18

44.25

u/ml

0.06

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

281

1119

1.78

17.37

1.2

61.33

87.44

u/ml

0.64

(3038026) Centromere Ab [Units/volume] in Serum

287

1153

1.76

17.23

1.2

16.75

53.83

u/ml

1.71

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

222

831

1.89

16.73

1.9

1.8

2.21

2.76

u/field

0.54

157

565

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.17

16.64

1.4

1.2

0.53

1.34

ml/s/173m2

6.69

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

267

1065

1.78

16.45

1.2

5.45

5.63

u/ml

0.02

(4281824) Cell count and differential, peritoneal fluid

340

1457

1.65

16.20

1.3

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

147

482

2.16

15.92

1.7

2.1

—

(3045424) Erythrocytes [Presence] in Urine

533

2545

1.49

15.89

1.7

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.60

15.64

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

163

565

2.04

15.32

1.6

1.7

14.54

12.39

umol/l

0.31

126

386

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

239

943

1.79

15.31

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

238

942

1.79

15.09

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

238

943

1.79

15.04

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

237

938

1.79

15.04

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

236

936

1.79

14.87

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

281

2.49

14.87

1.1

1.2

—

(3016228) CD19 cells/100 cells in Blood

167

591

2.00

14.86

1.8

2.1

7.20

8.27

0.48

160

574

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

400

2.23

14.79

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

236

939

1.78

14.72

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

426

1973

1.53

14.71

1.3

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

25.87

14.69

5.7

2.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1304

0.40

14.61

1.4

1.3

140.62

174.89

pmol/l

1.30

1304

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2100

17618

0.83

14.48

1.4

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

113

3.44

14.46

3.4

2.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

152

525

2.05

14.46

1.7

1.6

4.83

8.95

nmol/l

0.43

126

456

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

264

2.52

14.44

1.3

1.2

1.04

60.96

mg/l

1.25

201

(4146454) Self-monitoring of blood glucose

428

1996

1.52

14.33

2.9

2.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

102

302

2.39

14.04

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

161

575

1.98

14.00

1.8

2.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

123

3.27

13.94

1.4

1.9

0.71

1.25

mmol/l

1.14

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1604

13756

0.81

13.81

2.2

2.1

10.67

12.91

nmol/l

21.84

1353

12203

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

558

5503

0.71

13.76

1.5

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

19.41

13.61

3.7

1.6

—

(3002619) Bacteria identified in Specimen by Culture

269

2.44

13.48

1.5

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

200

2.69

13.30

2.1

2.0

—

(37019676) Renin [Units/volume] in Plasma --supine

6.12

13.25

1.0

1.2

47.80

54.94

mu/l

0.06

(40768443) Skin Pathology biopsy report

1269

7164

1.26

13.05

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

6142

39567

1.12

12.99

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

248

1040

1.69

12.94

2.1

1.7

8.02

6.83

mmol/l

4.72

173

707

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.41

12.79

2.3

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

858

4618

1.32

12.77

5.4

3.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

418

1991

1.49

12.72

1.7

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3506

21826

1.15

12.54

1.3

1.2

16.08

14.21

u/ml

0.33

1166

7750

(3006245) CD3-CD19+ cells/100 cells in Blood

126

429

2.08

12.52

2.1

13.41

10.97

0.60

111

389

(3036670) Protein [Mass/volume] in Synovial fluid

141

501

1.99

12.49

1.2

39.19

39.79

g/l

0.18

266

(3046861) Legionella sp Ag [Presence] in Urine

3.81

12.49

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

5.12

12.47

5.0

4.9

20.94

14.34

0.68

(3000963) Hemoglobin [Mass/volume] in Blood

23364

167718

0.87

12.38

50.0

19.6

127.87

136.62

g/l

307.65

23074

164669

(3026361) Erythrocytes [#/volume] in Blood

23361

167694

0.87

12.35

49.6

19.5

4.27

4.51

e12/l

307.65

22821

161477

(3006270) Folate [Moles/volume] in Blood

292

1293

1.60

12.35

1.3

1.2

298.22

348.98

nmol/l

3.84

233

1043

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

127

437

2.05

12.28

2.0

31.04

29.54

0.41

115

408

(3024731) MCV [Entitic volume]

23361

167686

0.87

12.28

49.4

19.4

92.26

91.40

125.26

23056

164628

(3019550) Sodium [Moles/volume] in Serum or Plasma

23305

161211

1.15

12.13

45.1

14.6

139.13

139.72

mmol/l

184.31

22959

156820

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1136

6386

1.27

12.13

2.4

3.5

813.82

1357.90

u/ml

0.59

940

5504

(3035941) MCH [Entitic mass]

23361

167659

0.87

12.06

49.4

19.4

30.30

30.49

39.46

23055

164614

(3010813) Leukocytes [#/volume] in Blood

23367

167684

0.87

11.93

49.6

19.5

7.58

6.68

e9/l

307.65

22824

161499

(3017315) Amylase [Enzymatic activity/volume] in Urine

201

815

1.75

11.87

1.3

1.2

221.57

361.99

u/l

1.19

191

747

(3007461) Platelets [#/volume] in Blood

23360

167610

0.87

11.71

49.6

19.5

234.90

244.20

e9/l

71.67

22876

162114

(4034850) Laboratory test

896

4919

1.29

11.57

20.3

8.8

—

(3020618) Glucose [Moles/volume] in Synovial fluid

4.60

11.53

1.1

1.0

5.84

5.72

mmol/l

0.05

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

123

431

2.02

11.37

2.0

21.71

47.33

u/l

2.02

109

394

(3013166) Neutrophils/100 leukocytes in Synovial fluid

131

473

1.96

11.16

1.4

1.3

74.40

52.67

12.58

114

400

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.62

11.13

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

23360

167529

0.88

11.07

50.6

19.6

38.41

40.50

137.79

21734

154928

(3050794) Legionella sp Ab [Presence] in Serum

124

2.96

10.92

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

168

664

1.79

10.86

1.1

1.09

1.07

ratio

1.35

211

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3412

21404

1.14

10.84

15.4

5.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

267

2.28

10.77

1.4

1.3

154.38

219.72

titre

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

421

1.98

10.43

2.7

3.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.17

10.34

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.05

10.27

1.0

1.1

146.38

211.28

pmol/l

0.42

(3019174) dRVVT (LA screen)

3.40

10.20

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23312

161576

1.13

10.06

45.4

14.7

4.06

3.98

mmol/l

286.46

22951

156916

(21494567) Legionella sp IgM Ab [Presence] in Serum

100

3.11

10.03

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.69

9.99

1.0

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

4.30

9.97

1.3

149.25

98.81

ug/l

0.48

(3001186) Copper [Moles/volume] in Serum or Plasma

273

2.20

9.88

1.1

1.2

17.76

16.27

umol/l

2.14

244

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

267

1224

1.54

9.84

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

101

349

2.05

9.77

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

707

3853

1.30

9.72

2.7

3.4

1486.98

672.50

u/ml

0.43

631

3505

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7603

57202

0.91

9.54

4.1

4.5

22.70

21.81

4.88

3660

29502

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.72

9.50

3.4

3.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

144

2.65

9.34

4.5

2.7

1.54

1.04

mg/l

1.27

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

366

1.99

9.26

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

263

2.18

9.20

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

263

2.18

9.20

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1200

10169

0.82

9.16

2.3

2.4

24.39

25.30

au/ml

0.06

629

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

279

2.13

9.03

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

314

1520

1.46

8.97

3.3

2.8

121.49

24.11

mg/l

3.82

239

1077

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

119

2.79

8.96

1.4

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.80

8.95

3.4

3.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1080

9207

0.82

8.78

1.3

41.13

58.37

au/ml

1.81

529

(3051387) C reactive protein [Mass/volume] in Capillary blood

606

3290

1.31

8.62

5.6

2.9

28.81

28.30

mg/l

0.12

444

2000

(3044009) aPTT.lupus sensitive (LA screen)

3.11

8.50

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

560

0.31

8.49

1.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

109

408

1.89

8.48

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

207

2234

0.65

8.44

1.9

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

136

549

1.75

8.32

1.4

1.5

15.05

28.02

umol/l

7.41

130

518

(3022145) Colonoscopy Study observation

2893

18260

1.13

8.27

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

486

4515

0.75

8.27

1.7

42.47

43.48

nmol/l

0.43

463

4352

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21606

155197

0.91

8.19

6.2

5.3

2.25

2.72

mmol/l

307.65

19926

140406

(3021374) Sirolimus [Mass/volume] in Blood

+∞

8.15

8.6

0.0

6.98

—

ug/l

—

(1002224) Polysomnography panel

544

4966

0.77

8.13

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

651

0.38

8.08

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

190

846

1.59

8.04

1.8

1.4

7.87

5.99

u/l

0.77

157

700

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

223

2.19

7.99

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

160

1799

0.63

7.91

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

140

580

1.71

7.85

2.1

2.3

57.87

52.19

umol/l

0.88

113

489

(3016244) Insulin [Units/volume] in Serum or Plasma

137

566

1.71

7.76

3.3

2.8

34.92

21.28

mu/l

1.93

120

529

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

336

1.93

7.74

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

18823

129532

1.08

7.71

39.5

15.7

15.92

15.23

32.10

18565

127053

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

414

2164

1.35

7.70

1.1

84.80

5893.50

iu/ml

0.56

413

(3020393) Adenovirus Ag [Presence] in Stool

151

2.43

7.67

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.47

7.61

2.2

1.6

183.59

198.96

ug/g

0.17

(3003338) MCHC [Mass/volume]

17055

123539

0.93

7.36

45.0

17.3

327.90

333.00

g/l

307.65

16866

122632

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

358

1.87

7.31

1.2

531.66

264.33

pmol/l

0.77

259

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

129

2.52

7.30

4.3

6.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

476

1.75

7.30

1.4

3179811.71

1424776.82

iu/ml

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

+∞

7.25

2.5

0.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

435

0.29

7.14

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

217

1029

1.49

6.99

1.7

2.0

545.95

2852.01

u/l

2.19

347

(3013637) Mi-2 Ab [Presence] in Serum

370

1.83

6.92

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

370

1.83

6.92

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

370

1.83

6.92

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

370

1.83

6.92

1.1

—

(40765096) Chromosome analysis panel by Banding

121

501

1.71

6.86

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

283

1420

1.41

6.80

1.8

3690.00

2542.11

titre

—

(36660697) Celiac disease serology panel - Serum

1692

10447

1.15

6.74

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21119

151562

0.92

6.69

5.6

4.7

4.02

4.62

mmol/l

307.65

19521

137716

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.64

6.47

1.1

1.25

1.11

u/field

0.56

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20925

150162

0.92

6.39

5.5

4.6

1.28

1.46

mmol/l

307.65

19214

135470

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

327

1702

1.36

6.34

1.1

—

(40768441) Liver Pathology biopsy report

213

1030

1.46

6.28

1.5

1.2

—

(3008898) HLA-B27 [Presence]

368

3396

0.76

6.08

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

304

1.86

6.08

1.2

1.3

128.94

59.98

mu/l

1.56

223

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.26

6.00

10.1

8.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.72

5.95

1.0

1.3

44.54

41.93

mg/l

—

(3035082) Kappa light chains [Mass/volume] in Urine

3.83

5.95

1.1

0.03

0.37

g/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

834

4923

1.20

5.81

1.6

—

(3036180) Methadone [Presence] in Urine

304

1.84

5.80

1.5

2.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

142

642

1.56

5.78

1.3

48.22

61.36

0.79

(3000060) B lymphocytes [#/volume] in Blood

306

1.82

5.69

1.9

2.0

1352.55

1672.64

e6/l

0.10

159

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

187

901

1.47

5.67

1.2

1.3

1.13

1.87

u/ml

0.86

117

531

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

144

657

1.55

5.64

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

921

5502

1.19

5.63

1.1

202.87

225.10

titre

0.07

144

(3035320) C reactive protein [Mass/volume] in Body fluid

211

1042

1.43

5.62

3.3

2.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

541

4717

0.81

5.62

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.18

5.57

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

361

1.74

5.52

1.6

0.42

0.35

ug/l

0.67

225

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

386

0.35

5.47

1.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

106

453

1.65

5.45

1.1

1627.39

1583.38

miu/ml

0.15

106

453

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.94

5.35

1.0

1.1

1.22

1.42

u/field

0.14

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

195

1.99

5.17

3.2

3.4

39.54

41.84

umol/l

0.28

170

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1947

15236

0.89

5.14

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

363

0.35

5.13

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

362

0.35

5.10

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.62

5.09

1.1

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.53

5.08

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

361

0.35

5.07

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

361

0.35

5.07

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

334

1.73

5.05

1.1

—

(40761511) CBC panel - Blood by Automated count

22475

156434

1.08

5.05

32.7

12.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

337

0.33

5.00

1.6

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.04

4.99

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

7.76

4.94

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

200

1004

1.41

4.93

1.2

10.69

9.20

mmol/l

4.28

183

954

(3018133) Calcium [Moles/volume] in Urine

189

1.98

4.92

1.4

1.7

2.16

2.73

mmol/l

1.16

165

(3043238) Trisomy 21 risk [Likelihood] in Fetus

311

0.32

4.87

1.4

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

220

1.89

4.83

1.1

1.3

32.15

46.67

mg/l

2.14

187

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

490

4243

0.81

4.83

3.6

1.6

6.58

3.49

mg/l

4.85

458

3072

(3025130) Human papilloma virus identified in Specimen

1082

0.63

4.83

2.0

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

274

1453

1.33

4.82

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

366

3273

0.79

4.82

1.8

1.9

180.24

200.58

pmol/l

3.16

342

3071

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

125

2.20

4.76

2.2

1.2

24.30

20.66

mmol/l

3.07

(3006969) Lambda light chains [Mass/volume] in Urine

3.64

4.72

1.0

1.1

0.02

g/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

305

1648

1.31

4.72

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

665

3926

1.20

4.71

1.3

—

(3000285) Sodium [Moles/volume] in Blood

203

1.91

4.66

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

302

0.33

4.62

1.5

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

382

1.65

4.57

2.5

137.85

142.55

nmol/l

0.16

332

(3005033) Fetal Nuchal fold Thickness US

300

0.33

4.56

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

401

1.62

4.46

1.5

1.3

29.34

38.51

1.44

274

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

127

1311

0.68

4.38

1.0

245.22

336.67

ng/l

6.90

900

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

7.06

4.31

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

1319

0.69

4.24

1.0

34.76

42.35

ng/l

2.60

891

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

263

1417

1.31

4.20

3.6

3.8

74.95

56.40

u/ml

0.51

254

1399

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

1315

0.69

4.17

1.0

744.38

714.10

ng/l

0.33

867

(3003327) Ova and parasites identified in Stool by Light microscopy

710

4267

1.18

4.16

1.6

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

101

1078

0.66

4.15

1.1

1.0

4.40

3.26

u/ml

0.25

501

(3039744) RNA polymerase III Ab [Units/volume] in Serum

102

2.21

4.01

1.1

1.0

10.50

2.89

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

364

1.61

3.97

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

3.97

1.0

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.31

3.90

1.3

0.88

0.59

u/field

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21200

151453

0.94

3.89

6.0

4.9

6.51

6.00

mmol/l

313.51

19219

135763

(3013293) Extractable nuclear Ab [Presence] in Serum

192

1.84

3.83

1.5

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

109

2.14

3.81

1.4

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

539

3191

1.20

3.79

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

219

1.77

3.76

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.80

3.70

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5854

43214

0.94

3.68

1.7

1.6

1.46

1.33

mmol/l

20.09

4898

35423

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

877

0.65

3.63

1.0

0.08

0.38

u/ml

1.12

282

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.97

3.55

1.0

1.2

—

mmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

131

1283

0.72

3.44

1.1

0.96

1.13

u/ml

0.17

649

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

452

1.50

3.43

1.3

1.2

38.27

20.79

0.74

(3042951) Complement C1q Ab [Units/volume] in Serum

2.63

3.42

1.5

1.1

32.98

9.74

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

150

1.88

3.33

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

110

536

1.45

3.33

2.6

2.9

30.18

28.49

umol/l

0.76

403

(40762887) Creatinine [Moles/volume] in Blood

3.09

3.30

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

224

2018

0.78

3.28

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

860

1.35

3.26

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

487

1.46

3.24

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

117

1.99

3.23

1.2

1.0

9.73

12.09

u/l

0.30

117

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

136

695

1.38

3.18

1.4

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.41

3.16

4.5

4.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

201

1.72

3.09

2.9

2.5

0.49

0.54

u/field

0.14

201

(3006462) Nitrate [Presence] in Urine

141

733

1.36

2.99

3.9

3.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

106

2.00

2.98

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2386

15706

1.08

2.97

2.0

2.2

202.22

143.96

ug/g

4.58

1904

12159

(3023430) Cat dander IgE Ab [Units/volume] in Serum

986

0.71

2.94

1.1

1.0

5.43

3.59

u/ml

0.25

388

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

851

1.33

2.93

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

207

1141

1.28

2.92

1.4

1.3

2.21

2.20

mmol/l

0.05

194

1059

(3028717) Thiamine [Mass/volume] in Blood

137

1.85

2.91

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

108

1058

0.72

2.91

1.1

—

(3013466) aPTT in Blood by Coagulation assay

2.28

2.88

1.1

1.2

37.32

37.18

0.03

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

401

1.48

2.88

1.2

1.3

138.02

133.56

nmol/l

0.06

286

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

559

0.62

2.86

1.2

—

(40768795) Lymph node Pathology biopsy report

288

1655

1.23

2.86

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

548

3339

1.16

2.84

1.3

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

317

1.54

2.83

1.1

0.70

0.67

umol/24h

0.16

149

(3030313) Adrenal Ab [Titer] in Serum

2.35

2.79

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

7.05

2.76

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

4.70

2.75

1.1

2.2

38.00

26.00

umol/l

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.70

2.75

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

808

6396

0.89

2.75

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.87

2.75

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1294

9988

0.91

2.74

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

799

0.69

2.74

1.1

1.4

1.49

1.54

g/l

0.60

799

(3028707) Methadone [Presence] in Urine by Screen method

178

972

1.29

2.73

2.4

3.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

189

1694

0.79

2.73

1.2

8.49

7.62

mmol/l

2.86

169

1415

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

106

538

1.39

2.65

7.6

12.7

772.83

845.89

nmol/l

0.86

515

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.23

2.59

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

399

1.45

2.59

1.7

1.6

10.88

9.13

ug/l

2.31

399

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1165

7484

1.10

2.59

1.2

103.56

136.27

iu/ml

2.40

377

2638

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

2.54

4.5

5.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

501

1.40

2.53

1.0

1.1

99.80

97.23

0.26

379

(3021162) Amylase [Enzymatic activity/volume] in Specimen

287

1.52

2.50

2.4

2.7

2265.32

1535.86

u/l

0.26

252

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

2.49

1.3

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

2.48

0.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.12

2.46

1.5

1.4

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.07

2.44

1.7

1.3

1.00

1.08

u/field

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

856

5437

1.11

2.39

1.1

46.86

6.11

u/ml

0.68

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

227

0.47

2.34

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

283

2385

0.84

2.32

1.5

1.4

25.24

32.33

iu/l

2.78

228

2012

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

136

0.36

2.32

1.0

—

(3001729) Color of Synovial fluid

122

1.79

2.32

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

809

1.29

2.31

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

149

1.71

2.28

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

518

3202

1.14

2.28

1.1

22.76

7.99

u/ml

1.07

299

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.13

2.27

1.3

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

171

1.65

2.26

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

171

1.65

2.26

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

171

1.65

2.26

1.3

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.09

2.20

1.5

1.6

2.09

1.31

mg/l

—

(3007147) Virus identified in Stool by Electron microscopy

4.70

2.17

1.0

—

(3027944) Amphetamines [Presence] in Urine

248

2096

0.83

2.13

2.5

2.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

2.12

0.0

1.0

—

164.03

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.06

2.12

1.1

1.0

—

(4212803) Bone marrow aspirate examination

175

1.61

2.09

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

126

0.39

2.08

8.3

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

127

0.39

2.08

4.1

2.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

166

936

1.25

2.06

1.7

2.2

16.03

16.54

nmol/l

0.37

154

873

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

188

1.58

2.02

1.6

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

194

1.56

2.00

1.3

1.2

7.50

5.84

mmol/l

0.78

(3035611) Eosinophils/100 leukocytes in Synovial fluid

102

1.80

2.00

1.5

1.6

1.09

0.73

0.28

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.96

1.97

1.7

1.5

0.33

0.23

u/l

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.89

1.96

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

257

2145

0.84

1.95

2.5

2.2

—

(40768793) Breast Pathology biopsy report

371

3009

0.87

1.95

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

119

1.72

1.94

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.07

1.93

1.3

1.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

3.06

0.90

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

1.72

1.96

mg/l

0.07

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

0.40

1.46

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

0.33

1.91

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

5.03

3.32

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

3.40

3.07

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

4.35

2.69

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

0.31

1.86

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.02

1.92

1.6

1.40

2.28

mg/l

—

(3002256) Pathology report gross observation

3149

21228

1.05

1.92

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

257

2139

0.85

1.90

2.5

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

166

1438

0.81

1.88

1.0

1.1

0.82

1.15

u/ml

0.44

613

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.50

1.87

1.0

1.5

—

1742.43

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

307

0.60

1.87

1.7

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

296

1.43

1.86

5.5

6.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.9

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.94

1.84

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

142

1246

0.80

1.83

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.12

1.81

1.1

1.0

—

(3018291) Platelet Ab [Presence] in Serum

2.65

1.78

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

174

1484

0.83

1.72

1.0

1.1

6.04

2.88

u/ml

0.92

718

(3000764) Benzodiazepines [Presence] in Urine

258

2123

0.86

1.69

2.4

2.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

152

1.58

1.69

1.1

—

(3015183) Erythrocyte sedimentation rate

508

0.71

1.67

2.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

181

1.52

1.65

1.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

0.47

1.65

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.98

1.65

1.1

1.3

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

3.92

1.65

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

200

1671

0.84

1.60

1.1

1.63

1.40

u/ml

0.10

853

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.28

1.58

1.3

1.0

2.27

2.59

0.19

(3019420) Tryptase [Mass/volume] in Serum or Plasma

115

645

1.26

1.58

1.5

10.94

8.79

ug/l

0.26

103

588

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.56

0.0

1.1

—

187.17

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

143

1226

0.82

1.53

4.8

5.1

65.39

103.84

u/ml

0.51

356

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

210

1.45

1.46

1.3

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

177

1480

0.84

1.46

1.1

—

28.60

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

825

1.22

1.44

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

450

2853

1.11

1.44

1.4

11.69

9.54

u/l

2.28

355

2287

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

0.49

1.42

1.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.21

1.40

1.2

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.67

1.39

1.7

1.5

202.53

194.79

ng/l

0.15

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

149

1.52

1.38

1.0

1.2

2.14

1.63

umol/24h

1.67

149

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.38

0.0

5.9

—

0.34

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.86

1.33

1.0

1.1

225.00

288.54

nmol/l

0.85

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

329

0.69

1.31

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22960

162803

0.96

1.29

17.3

10.3

26.99

26.27

u/l

1.31

22339

155629

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

405

1.29

1.2

1.3

0.33

0.31

g/l

2.17

331

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.97

1.25

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

710

0.79

1.24

1.1

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

514

1.25

1.24

1.6

2.10

1.99

umol/l

0.44

481

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

328

2065

1.12

1.23

3.5

3.3

14.74

8.58

nmol/l

0.67

319

2012

(3010370) Gastrin [Moles/volume] in Serum or Plasma

237

1.37

1.21

1.8

1.7

58.56

58.61

pmol/l

0.00

191

(3007463) Buprenorphine [Presence] in Urine

2.71

1.20

1.0

11.7

—

(3016879) Cocaine [Presence] in Urine

251

2003

0.88

1.16

2.5

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

412

1.27

1.15

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

264

1.34

1.14

1.3

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

110

1.54

1.14

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.57

1.13

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

553

1.23

1.12

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.65

1.12

1.7

1.8

1.41

1.45

umol/l

0.18

(3022689) Creatine [Moles/volume] in Urine

477

1.24

1.12

1.6

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

210

1296

1.14

1.11

1.9

2.0

3.94

3.55

ug/l

0.20

187

1193

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

191

0.63

1.10

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

378

1.27

1.09

1.2

113.33

111.84

0.18

335

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

138

0.56

1.09

1.2

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

655

0.81

1.05

1.0

1.1

320.37

697.94

ng/l

0.60

160

(42870560) Thyrotropin [Units/volume] in Cord blood

0.45

1.02

1.0

13.31

8.13

mu/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

1.38

1.00

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

537

3513

1.08

0.98

1.8

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

156

1.40

0.97

1.4

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

466

0.79

0.94

1.0

1.1

0.29

1.36

u/ml

2.94

119

(40762814) Titanium [Mass/volume] in Blood

368

1.25

0.93

2.1

2.3

3.55

3.48

ug/l

0.05

126

(3025577) Chromium [Mass/volume] in Blood

201

1259

1.13

0.90

2.0

2.1

2.03

2.30

ug/l

0.60

155

1064

(3036071) Salmonella sp Ab [Titer] in Serum

377

1.24

0.89

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.76

0.88

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

136

1.40

0.86

1.2

1.0

111.81

82.87

ug/l

0.86

100

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

699

0.84

0.86

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

162

1.35

0.81

1.9

13.70

17.14

umol/l

1.21

162

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.80

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

395

1.21

0.80

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.76

0.80

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

486

0.81

0.80

1.0

1.1

0.72

1.26

u/ml

0.56

164

(3027874) Urate [Moles/volume] in Urine

1.66

0.80

1.1

1.27

1.73

mmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.50

0.79

1.0

1.4

—

(3041184) Isoniazid [Presence] in Urine

1.84

0.78

2.5

2.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.53

0.78

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

333

1.23

0.77

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.20

0.76

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.72

0.76

1.1

1.4

216.00

618.18

nmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

165

1.33

0.74

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.07

0.74

1.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

234

1.27

0.73

1.6

2.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

368

1.21

0.72

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

401

1.20

0.71

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

553

0.84

0.69

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

403

1.19

0.68

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.52

0.68

1.2

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

180

1.29

0.68

1.5

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

256

1.24

0.67

1.0

1.1

0.33

1.29

u/ml

1.36

123

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

657

0.86

0.66

1.1

1.19

1.10

u/l

0.40

330

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10004

71306

0.98

0.66

4.7

5.3

3.30

3.61

ug/l

0.45

8738

63936

(40760409) HLA-A [Type] by High resolution

1.58

0.63

1.0

—

(40763590) HLA-DQ beta [Type]

1.58

0.63

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.58

0.63

1.0

—

(40760410) HLA-B [Type] by High resolution

1.58

0.63

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.66

0.63

1.0

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.54

0.62

1.0

0.05

0.10

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.54

0.62

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

253

1.23

0.61

1.3

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.61

0.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

108

858

0.89

0.58

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

135

855

1.11

0.58

1.1

8.63

6.47

nmol/l

0.22

177

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.48

0.58

1.0

1.1

29.80

22.42

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.48

0.58

1.0

1.1

67.60

31.95

u/ml

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.41

0.57

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

640

0.87

0.57

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.69

0.57

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

179

1.26

0.57

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

115

909

0.89

0.57

5.5

6.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

179

1381

0.91

0.56

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.63

0.55

1.2

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.52

0.55

1.1

1.0

0.01

0.09

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

180

1.25

0.55

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

1.26

0.55

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

488

3267

1.05

0.54

1.3

4.27

3.81

mmol/l

10.16

459

3069

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

100

793

0.89

0.54

4.9

5.3

293.69

1354.09

u/ml

0.62

141

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

232

1.22

0.53

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

180

1383

0.92

0.53

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

581

1.13

0.52

1.0

1.1

5.28

5.75

u/ml

0.08

(3013862) HLA-DP [Type]

1.49

0.51

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

115

730

1.11

0.50

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

242

1591

1.07

0.49

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

405

1.15

0.49

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

120

934

0.91

0.48

1.2

1.1

40.53

47.94

mg/l

1.15

784

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

116

739

1.11

0.48

1.0

1.1

8.97

11.05

iu/ml

0.45

148

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

133

1.27

0.48

1.5

1.2

11.14

26.00

—

(3017509) Phencyclidine [Presence] in Urine

1.41

0.48

1.6

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.32

0.47

1.1

14.60

14.55

nmol/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

115

1.29

0.46

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

386

0.86

0.44

1.0

0.21

1.07

u/ml

0.65

111

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

272

0.83

0.44

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

114

884

0.91

0.44

1.1

272.68

323.97

mg/l

1.90

776

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

317

1.16

0.43

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.42

0.0

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

162

1.22

0.41

19.8

6.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

333

1.14

0.40

1.2

—

(3020650) Glucose [Presence] in Urine

351

0.86

0.39

2.1

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.35

0.38

1.6

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

327

0.86

0.37

2.9

3.2

8.15

6.98

mg/l

0.42

266

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23044

162893

0.99

0.37

41.8

15.4

102.52

77.33

umol/l

307.65

23037

162842

(40768804) Tissue Pathology biopsy report

8898

63230

0.99

0.37

2.3

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.37

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

171

1.20

0.36

1.6

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

577

1.10

0.36

1.5

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

235

0.84

0.36

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

107

1.25

0.36

1.3

1.4

15.34

17.41

pmol/l

0.27

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.71

0.35

1.2

362.00

325.80

umol/24h

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

370

1.13

0.35

1.4

1.2

2.67

3.02

umol/l

0.41

342

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

120

1.23

0.35

1.1

1.4

0.13

0.15

nmol/l

0.43

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

909

6239

1.03

0.35

3.2

4.1

95.67

70.54

u/ml

0.79

877

5996

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20779

146176

1.01

0.34

32.9

12.5

66.35

78.37

ml/min/173m2

307.65

18521

119815

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.32

0.33

1.2

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

219

1.16

0.33

9.2

9.0

0.40

0.34

umol/l

0.37

202

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.23

0.32

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

476

3240

1.04

0.32

1.4

15.87

32.14

e6/l

1.42

388

2500

(1001926) Buprenorphine [Presence] in Urine by Screen method

222

1650

0.95

0.32

2.4

2.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

371

2515

1.04

0.31

1.6

1.8

443.50

286.85

mu/l

0.86

335

2321

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

124

0.80

0.30

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

142

1.19

0.30

1.8

1.3

8.68

7.08

mmol/l

1.72

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

129

1.20

0.30

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

476

3245

1.04

0.30

1.5

684.76

1526.53

e6/l

2.28

418

2634

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

116

0.79

0.30

3.1

2.6

4644.76

19.24

pmol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

235

1.14

0.29

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

369

1.11

0.29

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

311

2285

0.96

0.29

3.7

3.5

36.17

44.08

u/ml

0.49

293

2222

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.28

0.28

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

583

0.92

0.28

1.3

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.76

0.28

3.2

1.8

—

(3023410) Appearance of Cerebral spinal fluid

196

1452

0.95

0.27

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method

184

1365

0.95

0.26

4.1

3.3

—

(3044290) Cell count panel - Cerebral spinal fluid

444

3035

1.03

0.26

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20577

144827

1.01

0.26

5.0

4.1

1.40

1.29

mmol/l

76.50

18784

129269

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

285

0.89

0.24

1.1

1.7

3.03

2.50

ug/l

0.26

161

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

0.87

0.24

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

402

0.91

0.24

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

142

0.84

0.23

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

107

1.19

0.23

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

365

2495

1.03

0.23

1.5

1.4

248.08

183.34

pmol/l

1.06

356

2433

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

117

873

0.95

0.22

1.4

0.22

0.19

nmol/l

0.42

618

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.22

0.0

1.1

—

(3032641) Amino acids panel - Urine

0.00

0.22

0.0

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

248

1.11

0.22

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.18

0.21

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

651

1.06

0.21

1.2

1.3

6.23

6.09

mmol/l

0.55

612

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

542

3736

1.02

0.20

1.4

1.3

538.82

573.02

mg/l

0.83

520

3540

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.80

0.20

9.1

8.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

301

0.91

0.18

2.6

2.5

70.50

170.29

au/ml

—

(40758292) HTLV I+II Ab panel - Serum

224

1.10

0.18

1.6

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.24

0.18

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

239

1.09

0.17

1.4

47.67

51.13

0.15

105

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

124

838

1.04

0.16

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3048

21342

1.01

0.16

5.3

4.8

32.77

32.53

0.56

2335

13774

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.11

0.16

1.0

1.4

0.16

1.23

u/ml

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

233

1.09

0.16

3.2

75.86

147.94

ng/l

1.26

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.15

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

105

1.14

0.15

1.8

1.5

—

(44813793) Dust mix specific IgE antibody measurement

132

896

1.04

0.15

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

289

1.07

0.14

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

133

904

1.04

0.14

1.7

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.82

0.14

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

230

0.92

0.13

1.0

1.1

12.68

10.81

u/ml

0.14

112

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

104

0.88

0.11

1.2

1.6

11.63

11.34

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

234

0.93

0.10

1.9

2.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

156

1.09

0.10

1.0

1.1

—

(3024316) Viscosity of Plasma

1.13

0.10

2.4

1.9

1.51

1.84

mpas

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

648

1.03

0.10

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

669

1.03

0.09

1.2

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

620

0.97

0.09

1.0

1.1

—

(40758358) Immune stain study

0.87

0.07

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

104

1.09

0.06

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.91

0.06

1.2

1.5

0.57

1.88

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

114

0.93

0.05

2.7

2.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

157

0.94

0.05

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

385

1.03

0.04

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

120

0.94

0.04

1.3

1.5

59.30

39.81

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

201

1406

1.01

0.03

1.1

7.32

3.77

u/ml

0.67

522

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

310

0.98

0.02

2.0

1.9

30.67

6.60

ug/l

0.37

185

(3024666) Lithium [Moles/volume] in Serum or Plasma

571

1.01

0.02

14.1

11.9

0.63

0.64

mmol/l

0.19

518

(3038177) Helicobacter pylori Ab [Presence] in Serum

284

1993

1.01

0.02

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

133

930

1.01

0.02

1.3

31.11

30.01

u/l

0.13

107

754

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

104

0.95

0.01

2.2

2.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.05

0.01

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

151

1.03

0.00

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

102

1.04

0.00

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

665

1.00

0.00

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

387

1.00

0.00

1.5

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

123

1.03

0.00

1.1

1.0

1.67

0.58

u/ml

0.53

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.95

0.00

1.0

—

(3013762) Body weight Measured

1.01

0.00

1.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.01

-0.00

1.2

1.3

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.92

-0.00

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

0.98

-0.00

2.0

2.7

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

18.88

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.86

-0.00

1.0

1.1

—

0.14

u/ml

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HEARTFAIL_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_EXMORE	1.872 [1.73, 2.02]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 93309 out of 148974 females with I9_HEARTFAIL_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_EXMORE	2.348 [2.15, 2.57]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 81980 out of 134565 males with I9_HEARTFAIL_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have I9_HEARTFAIL_EXMORE.

N-year risk	Females	Males
1	0.132%	0.369%
5	0.847%	2.109%
10	2.075%	5.33%
15	3.635%	9.966%
20	6.203%	16.023%

Relationships between endpoints

↥

Index endpoint: I9_HEARTFAIL_EXMORE – Heart failure,strict

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Heart failure,strict

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints